Impact of age and gender on glioblastoma onset, progression, and management

Glioblastoma (GBM) is the most common primary malignant brain tumor in adults, while its frequency in pediatric patients is 10–15%. For this reason, age is considered one of the major risk factors for the development of GBM, as it correlates with cellular aging phenomena involving glial cells and fa...

Full description

Saved in:
Bibliographic Details
Published inMechanisms of ageing and development Vol. 211; p. 111801
Main Authors Colopi, Ambra, Fuda, Serena, Santi, Samuele, Onorato, Angelo, Cesarini, Valeriana, Salvati, Maurizio, Balistreri, Carmela Rita, Dolci, Susanna, Guida, Eugenia
Format Journal Article
LanguageEnglish
Published Ireland Elsevier B.V 01.04.2023
Subjects
Online AccessGet full text
ISSN0047-6374
1872-6216
1872-6216
DOI10.1016/j.mad.2023.111801

Cover

Abstract Glioblastoma (GBM) is the most common primary malignant brain tumor in adults, while its frequency in pediatric patients is 10–15%. For this reason, age is considered one of the major risk factors for the development of GBM, as it correlates with cellular aging phenomena involving glial cells and favoring the process of tumor transformation. Gender differences have been also identified, as the incidence of GBM is higher in males than in females, coupled with a worse outcome. In this review, we analyze age- and gender- dependent differences in GBM onset, mutational landscape, clinical manifestations, and survival, according to the literature of the last 20 years, focusing on the major risk factors involved in tumor development and on the mutations and gene alterations most frequently found in adult vs young patients and in males vs females. We then highlight the impact of age and gender on clinical manifestations and tumor localization and their involvement in the time of diagnosis and in determining the tumor prognostic value. •Glioblastoma is the most common primary malignant brain tumor in adults.•The incidence of glioblastoma is higher in males than in females•Chemotherapy is more effective in adult compared to pediatric patients
AbstractList Glioblastoma (GBM) is the most common primary malignant brain tumor in adults, while its frequency in pediatric patients is 10-15%. For this reason, age is considered one of the major risk factors for the development of GBM, as it correlates with cellular aging phenomena involving glial cells and favoring the process of tumor transformation. Gender differences have been also identified, as the incidence of GBM is higher in males than in females, coupled with a worse outcome. In this review, we analyze age- and gender- dependent differences in GBM onset, mutational landscape, clinical manifestations, and survival, according to the literature of the last 20 years, focusing on the major risk factors involved in tumor development and on the mutations and gene alterations most frequently found in adult vs young patients and in males vs females. We then highlight the impact of age and gender on clinical manifestations and tumor localization and their involvement in the time of diagnosis and in determining the tumor prognostic value.Glioblastoma (GBM) is the most common primary malignant brain tumor in adults, while its frequency in pediatric patients is 10-15%. For this reason, age is considered one of the major risk factors for the development of GBM, as it correlates with cellular aging phenomena involving glial cells and favoring the process of tumor transformation. Gender differences have been also identified, as the incidence of GBM is higher in males than in females, coupled with a worse outcome. In this review, we analyze age- and gender- dependent differences in GBM onset, mutational landscape, clinical manifestations, and survival, according to the literature of the last 20 years, focusing on the major risk factors involved in tumor development and on the mutations and gene alterations most frequently found in adult vs young patients and in males vs females. We then highlight the impact of age and gender on clinical manifestations and tumor localization and their involvement in the time of diagnosis and in determining the tumor prognostic value.
Glioblastoma (GBM) is the most common primary malignant brain tumor in adults, while its frequency in pediatric patients is 10-15%. For this reason, age is considered one of the major risk factors for the development of GBM, as it correlates with cellular aging phenomena involving glial cells and favoring the process of tumor transformation. Gender differences have been also identified, as the incidence of GBM is higher in males than in females, coupled with a worse outcome. In this review, we analyze age- and gender- dependent differences in GBM onset, mutational landscape, clinical manifestations, and survival, according to the literature of the last 20 years, focusing on the major risk factors involved in tumor development and on the mutations and gene alterations most frequently found in adult vs young patients and in males vs females. We then highlight the impact of age and gender on clinical manifestations and tumor localization and their involvement in the time of diagnosis and in determining the tumor prognostic value.
Glioblastoma (GBM) is the most common primary malignant brain tumor in adults, while its frequency in pediatric patients is 10–15%. For this reason, age is considered one of the major risk factors for the development of GBM, as it correlates with cellular aging phenomena involving glial cells and favoring the process of tumor transformation. Gender differences have been also identified, as the incidence of GBM is higher in males than in females, coupled with a worse outcome. In this review, we analyze age- and gender- dependent differences in GBM onset, mutational landscape, clinical manifestations, and survival, according to the literature of the last 20 years, focusing on the major risk factors involved in tumor development and on the mutations and gene alterations most frequently found in adult vs young patients and in males vs females. We then highlight the impact of age and gender on clinical manifestations and tumor localization and their involvement in the time of diagnosis and in determining the tumor prognostic value. •Glioblastoma is the most common primary malignant brain tumor in adults.•The incidence of glioblastoma is higher in males than in females•Chemotherapy is more effective in adult compared to pediatric patients
ArticleNumber 111801
Author Fuda, Serena
Onorato, Angelo
Santi, Samuele
Salvati, Maurizio
Dolci, Susanna
Guida, Eugenia
Balistreri, Carmela Rita
Colopi, Ambra
Cesarini, Valeriana
Author_xml – sequence: 1
  givenname: Ambra
  surname: Colopi
  fullname: Colopi, Ambra
  organization: Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
– sequence: 2
  givenname: Serena
  surname: Fuda
  fullname: Fuda, Serena
  organization: Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
– sequence: 3
  givenname: Samuele
  surname: Santi
  fullname: Santi, Samuele
  organization: Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
– sequence: 4
  givenname: Angelo
  surname: Onorato
  fullname: Onorato, Angelo
  organization: Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
– sequence: 5
  givenname: Valeriana
  surname: Cesarini
  fullname: Cesarini, Valeriana
  organization: Department of Biomedicine, Institute of Translational Pharmacology-CNR, Rome, Italy
– sequence: 6
  givenname: Maurizio
  surname: Salvati
  fullname: Salvati, Maurizio
  organization: Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy
– sequence: 7
  givenname: Carmela Rita
  surname: Balistreri
  fullname: Balistreri, Carmela Rita
  organization: Cellular and Molecular Laboratory, Department of Biomedicine, Neuroscience and Advanced Diagnostics (Bi.N.D.), University of Palermo, Corso Tukory 211, 90134 Palermo, Italy
– sequence: 8
  givenname: Susanna
  orcidid: 0000-0002-6864-3673
  surname: Dolci
  fullname: Dolci, Susanna
  email: dolci@uniroma2.it
  organization: Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
– sequence: 9
  givenname: Eugenia
  orcidid: 0000-0002-1690-3277
  surname: Guida
  fullname: Guida, Eugenia
  email: eugenia.guida@uniroma2.it
  organization: Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36996926$$D View this record in MEDLINE/PubMed
BookMark eNp9kLtOwzAUQC0EgvL4ABaUkaEpfiS2IyZU8ahAYoHZunFuK1eJXWwXib8nUFgYmKwrnXN1fY7Jvg8eCTlndMYok1fr2QDdjFMuZowxTdkemTCteCk5k_tkQmmlSilUdUSOU1pTSlnF5SE5ErJpZMPlhDwuhg3YXIRlASsswHfFCn2HsQi-WPUutD2kHAYY54R5WmxiWEVMyQU__cYH8KM5oM-n5GAJfcKzn_eEvN7dvswfyqfn-8X85qm0oha51FyDrljdYm1VZREptBKqmlbUgtbIucJONLatNVjGmRXCtlYJrKGiQJU4IZe7veMtb1tM2QwuWex78Bi2yXDViEY37Bu9-EG37YCd2UQ3QPwwvwFGQO0AG0NKEZfGugx5_F2O4HrDqPlKbdZmTG2-Uptd6tFkf8zf5f851zsHxzzvDqNJ1qG32LmINpsuuH_sTyaYlPg
CitedBy_id crossref_primary_10_1016_j_lfs_2024_123018
crossref_primary_10_1002_cnr2_70050
crossref_primary_10_1097_JS9_0000000000001224
crossref_primary_10_1016_j_ijbiomac_2024_137184
crossref_primary_10_1016_j_mad_2024_111952
crossref_primary_10_3389_fnut_2024_1489812
crossref_primary_10_3390_ph18030431
crossref_primary_10_3390_pharmaceutics16111389
crossref_primary_10_5114_pjr_192044
crossref_primary_10_3390_biomedicines12081822
crossref_primary_10_1016_j_heliyon_2024_e27189
crossref_primary_10_3390_nu16111792
crossref_primary_10_1016_j_ijscr_2025_111094
crossref_primary_10_1016_j_mad_2023_111850
crossref_primary_10_3389_fonc_2023_1306164
crossref_primary_10_26683_2786_4855_2024_3_49__59_71
crossref_primary_10_1080_26941899_2024_2415690
crossref_primary_10_1186_s43094_024_00608_2
crossref_primary_10_1097_OR9_0000000000000134
crossref_primary_10_3389_fonc_2024_1435605
crossref_primary_10_3390_cancers16081557
crossref_primary_10_1186_s12964_024_01819_z
crossref_primary_10_1016_j_bioactmat_2023_11_007
crossref_primary_10_7759_cureus_73797
crossref_primary_10_4103_crst_crst_250_23
crossref_primary_10_1093_jnen_nlae091
crossref_primary_10_7759_cureus_61165
crossref_primary_10_1016_j_bbih_2024_100859
crossref_primary_10_3390_ijms25137038
Cites_doi 10.1038/nature10833
10.1186/s13046-022-02251-2
10.1038/s41598-018-24580-z
10.2176/nmc.oa.2017-0167
10.1007/s00401-016-1545-1
10.1136/bmj.n1560
10.2217/cns-2017-0026
10.1093/neuonc/noz150
10.1210/endocr/bqab192
10.1056/NEJMoa043330
10.1136/bmjopen-2019-029686
10.1111/j.1750-3639.1993.tb00752.x
10.1158/1078-0432.CCR-19-3874
10.1007/s00401-012-0998-0
10.1016/j.cell.2013.09.034
10.1371/journal.pone.0055597
10.1016/j.prro.2014.03.012
10.1186/s13014-021-01962-8
10.1007/s11060-018-2957-7
10.3171/jns.1999.91.2.0251
10.1002/ijc.27972
10.2174/1874467211205010102
10.1200/JCO.1995.13.1.112
10.1016/j.wneu.2018.01.055
10.3389/fonc.2021.699594
10.1016/j.ijrobp.2009.04.054
10.1093/neuros/nyx349
10.3390/cancers13184731
10.1007/s10014-020-00363-1
10.1002/ijc.31759
10.1007/s00381-015-2945-6
10.2176/nmc.ra.2017-0003
10.1111/febs.15739
10.1093/neuonc/noq191
10.3171/jns.1978.49.3.0333
10.1007/s11060-016-2190-1
10.1093/neuonc/now207
10.1016/j.nicl.2016.03.007
10.1016/j.ccr.2010.03.017
10.3389/fphar.2020.00040
10.3322/caac.21492
10.1016/j.critrevonc.2008.02.005
10.1159/000170088
10.1038/sj.bjc.6602407
10.1093/neuonc/noaa295
10.1172/JCI71048
10.1038/s41598-021-98913-w
10.3389/fphar.2019.00200
10.1126/scitranslmed.aao5253
10.1007/s11547-021-01381-5
10.1002/cncr.32797
10.1038/s41467-022-34959-2
10.2174/156800912799277557
10.1002/ijc.30597
10.1093/neuonc/noy002
10.1007/s00381-012-1890-x
10.1016/j.clineuro.2018.12.021
10.1007/s11060-019-03335-4
10.1038/s41591-018-0337-7
10.1371/journal.pone.0142612
10.3171/2014.2.PEDS13352
10.1101/gad.1596707
10.2165/11594010-000000000-00000
10.3322/caac.21613
10.1158/1535-7163.MCT-12-1162
10.1007/s00381-015-3006-x
10.1002/cncr.24730
10.1093/neuonc/noac079.301
10.1016/j.ccell.2017.08.017
10.1002/ijc.11213
10.1111/bpa.12336
10.3171/jns.1998.89.1.0052
10.1038/sigtrans.2017.40
10.1038/nm.2963
10.1007/978-3-319-91442-8_3
10.1158/1078-0432.CCR-12-3002
10.1126/scisignal.2004088
10.1016/S1470-2045(18)30675-2
10.1186/s40478-018-0513-5
10.1016/j.cytogfr.2015.12.007
10.1016/j.ijrobp.2008.05.034
10.1182/blood-2008-10-184184
10.1007/s00401-015-1405-4
10.1093/aje/kwh154
10.1002/ijc.25864
10.1007/s00701-021-04802-6
10.1001/jamaoncol.2020.1024
10.4049/jimmunol.178.10.6465
10.1016/j.eplepsyres.2016.12.013
10.1016/j.ejca.2014.12.014
10.1016/j.jpeds.2011.12.006
10.1093/neuonc/noab106
10.1002/cncr.21539
10.1200/JCO.2017.76.0611
10.1007/s11060-019-03134-x
10.1007/s11060-018-03015-9
10.1186/s12943-022-01513-z
10.1007/s10552-009-9311-5
10.1007/s10552-013-0330-x
10.1016/j.canep.2021.101948
10.2741/4573
10.1002/pbc.28283
10.1093/neuonc/noz123
10.1093/jnci/djs315
10.1186/s13014-020-01584-6
10.1158/1055-9965.EPI-14-0275
ContentType Journal Article
Copyright 2023 Elsevier B.V.
Copyright © 2023 Elsevier B.V. All rights reserved.
Copyright_xml – notice: 2023 Elsevier B.V.
– notice: Copyright © 2023 Elsevier B.V. All rights reserved.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.mad.2023.111801
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
Zoology
EISSN 1872-6216
ExternalDocumentID 36996926
10_1016_j_mad_2023_111801
S0047637423000271
Genre Research Support, Non-U.S. Gov't
Journal Article
Review
GroupedDBID ---
--K
--M
-~X
.55
.GJ
.~1
0R~
1B1
1RT
1~.
1~5
29M
3O-
4.4
457
4G.
53G
5GY
5VS
7-5
71M
8P~
9JM
AACTN
AADPK
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AAXLA
AAXUO
AAYJJ
ABCQJ
ABFNM
ABFRF
ABGSF
ABJNI
ABMAC
ABUDA
ABXDB
ABYKQ
ACDAQ
ACGFO
ACGFS
ACIUM
ACNCT
ACRLP
ADBBV
ADEZE
ADMUD
ADUVX
AEBSH
AEFWE
AEHWI
AEKER
AENEX
AFKWA
AFTJW
AFXIZ
AGHFR
AGRDE
AGUBO
AGWIK
AGYEJ
AHHHB
AHPSJ
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
CS3
DOVZS
DU5
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HLW
HMQ
HVGLF
HZ~
IHE
J1W
KOM
LX3
M2V
M41
MO0
MOBAO
MS~
MVM
N9A
O-L
O9-
OAUVE
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
ROL
RPZ
SBG
SCC
SDF
SDG
SDP
SES
SEW
SNS
SPCBC
SSN
SSU
SSZ
T5K
WUQ
X7M
YYP
ZGI
ZXP
~G-
AATTM
AAXKI
AAYWO
AAYXX
ABWVN
ACRPL
ACVFH
ADCNI
ADNMO
AEIPS
AEUPX
AFJKZ
AFPUW
AGCQF
AGQPQ
AGRNS
AIGII
AIIUN
AKBMS
AKRWK
AKYEP
ANKPU
APXCP
BNPGV
CITATION
SSH
CGR
CUY
CVF
ECM
EIF
NPM
7X8
EFKBS
ID FETCH-LOGICAL-c353t-828a8415be5c74cee0ab6a45040ca88e227ed39cb58ac121c33cbc73e5a40a073
IEDL.DBID AIKHN
ISSN 0047-6374
1872-6216
IngestDate Fri Sep 05 02:55:28 EDT 2025
Wed Feb 19 02:23:41 EST 2025
Tue Jul 01 04:17:46 EDT 2025
Thu Apr 24 22:57:33 EDT 2025
Fri Feb 23 02:34:48 EST 2024
IsPeerReviewed true
IsScholarly true
Keywords Gender
Age
Glioblastoma
High grade glioma
Language English
License Copyright © 2023 Elsevier B.V. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c353t-828a8415be5c74cee0ab6a45040ca88e227ed39cb58ac121c33cbc73e5a40a073
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ORCID 0000-0002-6864-3673
0000-0002-1690-3277
PMID 36996926
PQID 2793989107
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2793989107
pubmed_primary_36996926
crossref_citationtrail_10_1016_j_mad_2023_111801
crossref_primary_10_1016_j_mad_2023_111801
elsevier_sciencedirect_doi_10_1016_j_mad_2023_111801
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate April 2023
2023-04-00
20230401
PublicationDateYYYYMMDD 2023-04-01
PublicationDate_xml – month: 04
  year: 2023
  text: April 2023
PublicationDecade 2020
PublicationPlace Ireland
PublicationPlace_xml – name: Ireland
PublicationTitle Mechanisms of ageing and development
PublicationTitleAlternate Mech Ageing Dev
PublicationYear 2023
Publisher Elsevier B.V
Publisher_xml – name: Elsevier B.V
References Broestl, Rubin (bib14) 2021; 162
Cordier, Monfort, Filippini, Preston-Martin, Lubin, Mueller, Holly, Peris-Bonet, McCredie, Choi, Little, Arslan (bib21) 2004; 159
Lombardi, De Salvo, Brandes, Eoli, Ruda, Faedi, Lolli, Pace, Daniele, Pasqualetti, Rizzato, Bellu, Pambuku, Farina, Magni, Indraccolo, Gardiman, Soffietti, Zagonel (bib58) 2019; 20
Ostrom, Gittleman, Xu, Kromer, Wolinsky, Kruchko, Barnholtz-Sloan (bib73) 2016; 18
Fyllingen, Bo, Reinertsen, Jakola, Sagberg, Berntsen, Salvesen, Solheim (bib36) 2021; 163
Abou-Elkacem, Arns, Brix, Gremse, Zopf, Kiessling, Lederle (bib1) 2013; 12
Malbec, Roget, Schiffer, Iannascoli, Dumas, Arock, Daeron (bib64) 2007; 178
M, Snijders, de Graeff, Teunissen, de Vos (bib62) 2018; 140
Toledo, Sarria-Estrada, Quintana, Maldonado, Martinez-Ricarte, Rodon, Auger, Aizpurua, Salas-Puig, Santamarina, Martinez-Saez (bib102) 2017; 130
Hanif, Muzaffar, Perveen, Malhi, Simjee Sh (bib40) 2017; 18
Schwartzbaum, Ding, Johannesen, Osnes, Karavodin, Ahlbom, Feychting, Grimsrud (bib91) 2012; 104
Li, McLaughlin, Infante-Rivard (bib57) 2009; 20
Brennan, Verhaak, McKenna, Campos, Noushmehr, Salama, Zheng, Chakravarty, Sanborn, Berman, Beroukhim, Bernard, Wu, Genovese, Shmulevich, Barnholtz-Sloan, Zou, Vegesna, Shukla, Ciriello, Yung, Zhang, Sougnez, Mikkelsen, Aldape, Bigner, Van Meir, Prados, Sloan, Black, Eschbacher, Finocchiaro, Friedman, Andrews, Guha, Iacocca, O'Neill, Foltz, Myers, Weisenberger, Penny, Kucherlapati, Perou, Hayes, Gibbs, Marra, Mills, Lander, Spellman, Wilson, Sander, Weinstein, Meyerson, Gabriel, Laird, Haussler, Getz, Chin (bib12) 2013; 155
Korshunov, Ryzhova, Hovestadt, Bender, Sturm, Capper, Meyer, Schrimpf, Kool, Northcott, Zheludkova, Milde, Witt, Kulozik, Reifenberger, Jabado, Perry, Lichter, von Deimling, Pfister, Jones (bib51) 2015; 129
Louis, Perry, Reifenberger, von Deimling, Figarella-Branger, Cavenee, Ohgaki, Wiestler, Kleihues, Ellison (bib60) 2016; 131
Daudigeos-Dubus, Le Dret, Lanvers-Kaminsky, Bawa, Opolon, Vievard, Villa, Pages, Bosq, Vassal, Zopf, Geoerger (bib25) 2015; 10
Thakkar, Dolecek, Horbinski, Ostrom, Lightner, Barnholtz-Sloan, Villano (bib101) 2014; 23
Li, Sun, He, Yin, Du, Zhang (bib56) 2018; 112
Fukai, Arita, Umehara, Yoshioka, Shofuda, Kanematsu, Kodama, Mano, Kinoshita, Okita, Nonaka, Uda, Tsuyuguchi, Sakamoto, Uematsu, Nakao, Mori, Kanemura (bib34) 2020; 37
Chatwin, Cruz Cruz, Green (bib17) 2021; 288
Jiang, Fang, Bao, Zhou, Shen, Ding, Chen, Hu, Lu (bib43) 2013; 8
Ozawa, Brennan, Zienius, Kurian, Hollingworth, Weller, Grant, Hamilton, Ben-Shlomo (bib80) 2019; 9
Adams, Adams, Jackson, Rincon-Torroella, Jallo, Quinones-Hinojosa (bib2) 2016; 32
Vanan, Eisenstat (bib105) 2014; 1
Mackay, Burford, Carvalho, Izquierdo, Fazal-Salom, Taylor, Bjerke, Clarke, Vinci, Nandhabalan, Temelso, Popov, Molinari, Raman, Waanders, Han, Gupta, Marshall, Zacharoulis, Vaidya, Mandeville, Bridges, Martin, Al-Sarraj, Chandler, Ng, Li, Mu, Trabelsi, Brahim, Kisljakov, Konovalov, Moore, Carcaboso, Sunol, de Torres, Cruz, Mora, Shats, Stavale, Bidinotto, Reis, Entz-Werle, Farrell, Cryan, Crimmins, Caird, Pears, Monje, Debily, Castel, Grill, Hawkins, Nikbakht, Jabado, Baker, Pfister, Jones, Fouladi, von Bueren, Baudis, Resnick, Jones (bib63) 2017; 32
Taylor, Furnari, Cavenee (bib100) 2012; 12
Ladomersky, Scholtens, Kocherginsky, Hibler, Bartom, Otto-Meyer, Zhai, Lauing, Choi, Sosman, Wu, Zhang, Lukas, Wainwright (bib52) 2019; 10
Brodbelt, Greenberg, Winters, Williams, Vernon, Collins (bib13) 2015; 51
Patil, Kelly, Yeboa, Buerki, Cioffi, Balaji, Ostrom, Kruchko, Barnholtz-Sloan (bib82) 2021; 23
Chieffo, Tamburrini, Caldarelli, Di Rocco (bib18) 2014; 13
Lehrer, Rheinstein, Rosenzweig (bib54) 2019; 177
Schreck, Ranjan, Skorupan, Bettegowda, Eberhart, Ames, Holdhoff (bib90) 2019; 143
Gao, Aksoy, Dogrusoz, Dresdner, Gross, Sumer, Sun, Jacobsen, Sinha, Larsson, Cerami, Sander, Schultz (bib37) 2013; 6
D'Alessio, Proietti, Sica, Scicchitano (bib22) 2019; 11
Ostrom, Cioffi, Gittleman, Patil, Waite, Kruchko, Barnholtz-Sloan (bib77) 2019; 21
Baumann, Tichy, Schaefer, Steinbach, Mittelbronn, Wagner, Foerch (bib6) 2020; 146
Ettrich, Seufferlein (bib30) 2018; 211
Khuong-Quang, Buczkowicz, Rakopoulos, Liu, Fontebasso, Bouffet, Bartels, Albrecht, Schwartzentruber, Letourneau, Bourgey, Bourque, Montpetit, Bourret, Lepage, Fleming, Lichter, Kool, von Deimling, Sturm, Korshunov, Faury, Jones, Majewski, Pfister, Jabado, Hawkins (bib47) 2012; 124
Khan, Prajapati, Lakhina, Sharma, Prajapati, Chosdol, Sinha (bib46) 2021; 11
Noushmehr, H., D.J. Weisenberger, K. Diefes, H.S. Phillips, K. Pujara, B.P. Berman, F. Pan, C.E. Pelloski, E.P. Sulman, K.P. Bhat, R.G. Verhaak, K.A. Hoadley, D.N. Hayes, C.M. Perou, H.K. Schmidt, L. Ding, R.K. Wilson, D. Van Den Berg, H. Shen, H. Bengtsson, P. Neuvial, L.M. Cope, J. Buckley, J.G. Herman, S.B. Baylin, P.W. Laird, K. Aldape and N. Cancer Genome Atlas Research (2010). "Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma." Cancer Cell
Alhalaseh, Abdulelah, Abu-Shanab, Armouti, Amarin, Mansour, Sultan, Al-Hussaini (bib3) 2021; 73
Das, Mehrotra, Nair, Kumar, Srivastava, Sahu, Kumar (bib23) 2012; 28
Mizumoto, Tsuboi, Igaki, Yamamoto, Takano, Oshiro, Hayashi, Hashii, Kanemoto, Nakayama, Sugahara, Sakurai, Matsumura, Tokuuye (bib67) 2010; 77
Yang, Wu, Zhang, Zhang, Wu, Wang, Dai, Zhang, Zhang, Peng, Ye, Zeng, Liu, Cheng (bib112) 2022; 21
Zawlik, Vaccarella, Kita, Mittelbronn, Franceschi, Ohgaki (bib116) 2009; 32
Kleihues, Burger, Scheithauer (bib49) 1993; 3
Huang, Li, Li, Zhang, Zong, Zhang (bib41) 2020; 11
Pacifici, Shore (bib81) 2016; 27
Mizumoto, Oshiro, Yamamoto, Kohzuki, Sakurai (bib69) 2017; 57
Tamimi, Juweid (bib98) 2017
Cohen, Pollack, Zhou, Buxton, Holmes, Burger, Brat, Rosenblum, Hamilton, Lavey, Heideman (bib20) 2011; 13
Solomon, Wood, Tihan, Bollen, Gupta, Phillips, Perry (bib94) 2016; 26
Stupp, Mason, van den Bent, Weller, Fisher, Taphoorn, Belanger, Brandes, Marosi, Bogdahn, Curschmann, Janzer, Ludwin, Gorlia, Allgeier, Lacombe, Cairncross, Eisenhauer, Mirimanoff (bib95) 2005; 352
Bains, Antia, Callard, Yates (bib5) 2009; 113
Santosh, Rao (bib87) 2022; 65
Wolff, Driever, Erdlenbruch, Kortmann, Rutkowski, Pietsch, Parker, Metz, Gnekow, Kramm (bib110) 2010; 116
Bray, Ferlay, Soerjomataram, Siegel, Torre, Jemal (bib11) 2018; 68
Dobran, Nasi, Chiriatti, Gladi, Somma, Iacoangeli, Scerrati (bib27) 2018; 58
Grill, Massimino, Bouffet, Azizi, McCowage, Canete, Saran, Le Deley, Varlet, Morgan, Jaspan, Jones, Giangaspero, Smith, Garcia, Elze, Rousseau, Abrey, Hargrave, Vassal (bib39) 2018; 36
Ostrom, Adel Fahmideh, Cote, Muskens, Schraw, Scheurer, Bondy (bib78) 2019; 21
Finlay, Boyett, Yates, Wisoff, Milstein, Geyer, Bertolone, McGuire, Cherlow, Tefft (bib31) 1995; 13
Konig, Jakel, von Knebel Doeberitz, Kieser, Eberle, Munter, Debus, Herfarth (bib50) 2021; 16
Ohgaki, Kleihues (bib72) 2013; 19
Cameron, Whiteside, Perry (bib15) 2011; 71
Ladomersky, Zhai, Lauing, Bell, Xu, Kocherginsky, Zhang, Wu, Podojil, Platanias, Mochizuki, Prins, Kumthekar, Raizer, Dixit, Lukas, Horbinski, Wei, Zhou, Pawelec, Campisi, Grohmann, Prendergast, Munn, Wainwright (bib53) 2020; 26
Sim, Morgan, Mason (bib93) 2018; 7
Press, Shafer, Jiang, Buchwald, Abugideiri, Tian, Morgan, Behera, Sengupta, Voloschin, Olson, Hasan, Blumenthal, Curran, Eaton, Shu, Zhong (bib85) 2020; 126
Yang, Warrington, Taylor, Whitmire, Carrasco, Singleton, Wu, Lathia, Berens, Kim, Barnholtz-Sloan, Swanson, Luo, Rubin (bib113) 2019; 11
Furnari, Fenton, Bachoo, Mukasa, Stommel, Stegh, Hahn, Ligon, Louis, Brennan, Chin, DePinho, Cavenee (bib35) 2007; 21
Malmer, Henriksson, Gronberg (bib65) 2003; 106
Schaefer, Kim, Albers, Hoermann, Myers, Whiteside (bib89) 2005; 92
Brandes, Tosoni, Franceschi, Reni, Gatta, Vecht (bib10) 2008; 67
Iacob, Dinca (bib42) 2009; 2
Ostrom, Rubin, Lathia, Berens, Barnholtz-Sloan (bib75) 2018; 20
Bailey, Rios, Lacour, Guerrini-Rousseau, Bertozzi, Leblond, Faure-Conter, Pellier, Freycon, Michon, Puget, Ducassou, Orsi, Clavel (bib4) 2017; 140
Esquenazi, Moussazadeh, Link, Hovinga, Reiner, DiStefano, Brennan, Gutin, Tabar (bib29) 2018; 83
Yang, Jin, Pang, Huang, Wang, Zhang, Tuo, Wu, Wang, Zhu (bib114) 2020; 11
Zhang, Stevens, Bradshaw (bib117) 2012; 5
Fisher, Reynolds, Von Behren, Carmichael, Rasmussen, Shaw (bib32) 2012; 160
Greenop, Peters, Fritschi, Glass, Ashton, Bailey, Scott, Daubenton, de Klerk, Armstrong, Milne (bib38) 2014; 25
Lombardi, Caccese, Padovan, Cerretti, Pintacuda, Manara, Di Sarra, Zagonel (bib59) 2021; 13
Nikitovic, Stanic, Pekmezovic, Gazibara, Bokun, Paripovic, Grujicic, Saric, Miskovic (bib70) 2016; 32
Yang, Chen, Sun, Chen, Yang, Ma, Yang (bib115) 2021; 11
Ostrom, Kinnersley, Armstrong, Rice, Chen, Wiencke, McCoy, Hansen, Amos, Bernstein, Claus, Eckel-Passow, Il'yasova, Johansen, Lachance, Lai, Merrell, Olson, Sadetzki, Schildkraut, Shete, Rubin, Andersson, Rajaraman, Chanock, Linet, Wang, Yeager, GliomaScan, Houlston, Jenkins, Wrensch, Melin, Bondy, Barnholtz-Sloan (bib76) 2018; 143
Li, Yu, Lee, Tsang, Krishnan, Weyand, Goronzy (bib55) 2012; 18
Das, K.K. and R. Kumar (2017). Pediatric Glioblastoma. Glioblastoma. S. De Vleeschouwer. Brisbane (AU).
Kim, Ladomersky, Mozny, Kocherginsky, O'Shea, Reinstein, Zhai, Bell, Lauing, Bollu, Rabin, Dixit, Kumthekar, Platanias, Hou, Zheng, Wu, Zhang, Hrachova, Merrill, Mrugala, Prabhu, Horbinski, James, Yamini, Ostrom, Johnson, Reardon, Lukas, Wainwright (bib48) 2021; 3
Schwartzentruber, Korshunov, Liu, Jones, Pfaff, Jacob, Sturm, Fontebasso, Quang, Tonjes, Hovestadt, Albrecht, Kool, Nantel, Konermann, Lindroth, Jager, Rausch, Ryzhova, Korbel, Hielscher, Hauser, Garami, Klekner, Bognar, Ebinger, Schuhmann, Scheurlen, Pekrun, Fruhwald, Roggendorf, Kramm, Durken, Atkinson, Lepage, Montpetit, Zakrzewska, Zakrzewski, Liberski, Dong, Siegel, Kulozik, Zapatka, Guha, Malkin, Felsberg, Reifenberger, von Deimling, Ichimura, Collins, Witt, Milde, Witt, Zhang, Castelo-Branco, Lichter, Faury, Tabori, Plass, Majewski, Pfister, Jabado (bib92) 2012; 482
Sun, Warrington, Luo, Brooks, Dahiya, S
Cameron (10.1016/j.mad.2023.111801_bib15) 2011; 71
Sasaki (10.1016/j.mad.2023.111801_bib88) 2018; 140
Li (10.1016/j.mad.2023.111801_bib57) 2009; 20
Schaefer (10.1016/j.mad.2023.111801_bib89) 2005; 92
Sun (10.1016/j.mad.2023.111801_bib97) 2014; 124
Fisher (10.1016/j.mad.2023.111801_bib32) 2012; 160
Abou-Elkacem (10.1016/j.mad.2023.111801_bib1) 2013; 12
Toledo (10.1016/j.mad.2023.111801_bib102) 2017; 130
Cloughesy (10.1016/j.mad.2023.111801_bib19) 2019; 25
Taylor (10.1016/j.mad.2023.111801_bib100) 2012; 12
Tsien (10.1016/j.mad.2023.111801_bib104) 2009; 73
Louis (10.1016/j.mad.2023.111801_bib61) 2021; 23
Ozawa (10.1016/j.mad.2023.111801_bib80) 2019; 9
Walker (10.1016/j.mad.2023.111801_bib106) 1978; 49
Cohen (10.1016/j.mad.2023.111801_bib20) 2011; 13
Fitzek (10.1016/j.mad.2023.111801_bib33) 1999; 91
10.1016/j.mad.2023.111801_bib71
Wang (10.1016/j.mad.2023.111801_bib107) 2022; 13
M (10.1016/j.mad.2023.111801_bib62) 2018; 140
Bilello (10.1016/j.mad.2023.111801_bib8) 2016; 12
Greenop (10.1016/j.mad.2023.111801_bib38) 2014; 25
Mackay (10.1016/j.mad.2023.111801_bib63) 2017; 32
Broestl (10.1016/j.mad.2023.111801_bib14) 2021; 162
Li (10.1016/j.mad.2023.111801_bib55) 2012; 18
Schwartzbaum (10.1016/j.mad.2023.111801_bib91) 2012; 104
Iacob (10.1016/j.mad.2023.111801_bib42) 2009; 2
Wilhelm (10.1016/j.mad.2023.111801_bib108) 2011; 129
Solomon (10.1016/j.mad.2023.111801_bib94) 2016; 26
Peters (10.1016/j.mad.2023.111801_bib84) 2013; 132
Lombardi (10.1016/j.mad.2023.111801_bib59) 2021; 13
Malbec (10.1016/j.mad.2023.111801_bib64) 2007; 178
Patil (10.1016/j.mad.2023.111801_bib82) 2021; 23
Zawlik (10.1016/j.mad.2023.111801_bib116) 2009; 32
Hanif (10.1016/j.mad.2023.111801_bib40) 2017; 18
Khuong-Quang (10.1016/j.mad.2023.111801_bib47) 2012; 124
Wisoff (10.1016/j.mad.2023.111801_bib109) 1998; 89
Brodbelt (10.1016/j.mad.2023.111801_bib13) 2015; 51
Fyllingen (10.1016/j.mad.2023.111801_bib36) 2021; 163
Ostrom (10.1016/j.mad.2023.111801_bib78) 2019; 21
Yang (10.1016/j.mad.2023.111801_bib113) 2019; 11
Lombardi (10.1016/j.mad.2023.111801_bib58) 2019; 20
Ostrom (10.1016/j.mad.2023.111801_bib76) 2018; 143
Gao (10.1016/j.mad.2023.111801_bib37) 2013; 6
Sim (10.1016/j.mad.2023.111801_bib93) 2018; 7
Bausart (10.1016/j.mad.2023.111801_bib7) 2022; 41
Schreck (10.1016/j.mad.2023.111801_bib90) 2019; 143
Ladomersky (10.1016/j.mad.2023.111801_bib52) 2019; 10
Malmer (10.1016/j.mad.2023.111801_bib65) 2003; 106
Nikitovic (10.1016/j.mad.2023.111801_bib70) 2016; 32
Pearson (10.1016/j.mad.2023.111801_bib83) 2017; 2
Grill (10.1016/j.mad.2023.111801_bib39) 2018; 36
Kleihues (10.1016/j.mad.2023.111801_bib49) 1993; 3
Schwartzentruber (10.1016/j.mad.2023.111801_bib92) 2012; 482
Yang (10.1016/j.mad.2023.111801_bib112) 2022; 21
Pacifici (10.1016/j.mad.2023.111801_bib81) 2016; 27
Chatwin (10.1016/j.mad.2023.111801_bib17) 2021; 288
Fukai (10.1016/j.mad.2023.111801_bib34) 2020; 37
Mizumoto (10.1016/j.mad.2023.111801_bib68) 2015; 5
Ladomersky (10.1016/j.mad.2023.111801_bib53) 2020; 26
Bailey (10.1016/j.mad.2023.111801_bib4) 2017; 140
Louis (10.1016/j.mad.2023.111801_bib60) 2016; 131
Alhalaseh (10.1016/j.mad.2023.111801_bib3) 2021; 73
Vanan (10.1016/j.mad.2023.111801_bib105) 2014; 1
Wu (10.1016/j.mad.2023.111801_bib111) 2017; 22
McKinnon (10.1016/j.mad.2023.111801_bib66) 2021; 374
Baumann (10.1016/j.mad.2023.111801_bib6) 2020; 146
Ostrom (10.1016/j.mad.2023.111801_bib73) 2016; 18
10.1016/j.mad.2023.111801_bib24
Yang (10.1016/j.mad.2023.111801_bib114) 2020; 11
Adams (10.1016/j.mad.2023.111801_bib2) 2016; 32
Reardon (10.1016/j.mad.2023.111801_bib86) 2020; 6
Wolff (10.1016/j.mad.2023.111801_bib110) 2010; 116
Bray (10.1016/j.mad.2023.111801_bib11) 2018; 68
Furnari (10.1016/j.mad.2023.111801_bib35) 2007; 21
Bains (10.1016/j.mad.2023.111801_bib5) 2009; 113
Esquenazi (10.1016/j.mad.2023.111801_bib29) 2018; 83
Thakkar (10.1016/j.mad.2023.111801_bib101) 2014; 23
Finlay (10.1016/j.mad.2023.111801_bib31) 1995; 13
Lehrer (10.1016/j.mad.2023.111801_bib54) 2019; 177
Cordier (10.1016/j.mad.2023.111801_bib21) 2004; 159
Khan (10.1016/j.mad.2023.111801_bib46) 2021; 11
Tamimi (10.1016/j.mad.2023.111801_bib98) 2017
Dunkel (10.1016/j.mad.2023.111801_bib28) 2022; 24
Kfoury (10.1016/j.mad.2023.111801_bib45) 2018; 6
Ostrom (10.1016/j.mad.2023.111801_bib77) 2019; 21
Stupp (10.1016/j.mad.2023.111801_bib95) 2005; 352
Ettrich (10.1016/j.mad.2023.111801_bib30) 2018; 211
Yang (10.1016/j.mad.2023.111801_bib115) 2021; 11
Huang (10.1016/j.mad.2023.111801_bib41) 2020; 11
Mizumoto (10.1016/j.mad.2023.111801_bib69) 2017; 57
Trone (10.1016/j.mad.2023.111801_bib103) 2020; 15
Kim (10.1016/j.mad.2023.111801_bib48) 2021; 3
Kanderi (10.1016/j.mad.2023.111801_bib44) 2022
Blumenthal (10.1016/j.mad.2023.111801_bib9) 2016; 129
Tan (10.1016/j.mad.2023.111801_bib99) 2020; 70
Chakrabarti (10.1016/j.mad.2023.111801_bib16) 2005; 104
Chieffo (10.1016/j.mad.2023.111801_bib18) 2014; 13
Dobran (10.1016/j.mad.2023.111801_bib27) 2018; 58
Ohgaki (10.1016/j.mad.2023.111801_bib72) 2013; 19
Daudigeos-Dubus (10.1016/j.mad.2023.111801_bib25) 2015; 10
Santosh (10.1016/j.mad.2023.111801_bib87) 2022; 65
Su (10.1016/j.mad.2023.111801_bib96) 2020; 67
Brandes (10.1016/j.mad.2023.111801_bib10) 2008; 67
Jiang (10.1016/j.mad.2023.111801_bib43) 2013; 8
Ostrom (10.1016/j.mad.2023.111801_bib75) 2018; 20
Ostrom (10.1016/j.mad.2023.111801_bib79) 2021; 23
Press (10.1016/j.mad.2023.111801_bib85) 2020; 126
Das (10.1016/j.mad.2023.111801_bib23) 2012; 28
Zhang (10.1016/j.mad.2023.111801_bib117) 2012; 5
Ostrom (10.1016/j.mad.2023.111801_bib74) 2018; 8
Mizumoto (10.1016/j.mad.2023.111801_bib67) 2010; 77
Detti (10.1016/j.mad.2023.111801_bib26) 2021; 126
Konig (10.1016/j.mad.2023.111801_bib50) 2021; 16
Li (10.1016/j.mad.2023.111801_bib56) 2018; 112
Brennan (10.1016/j.mad.2023.111801_bib12) 2013; 155
D'Alessio (10.1016/j.mad.2023.111801_bib22) 2019; 11
Korshunov (10.1016/j.mad.2023.111801_bib51) 2015; 129
References_xml – volume: 8
  year: 2013
  ident: bib43
  article-title: Association between the XRCC1 polymorphisms and glioma risk: a meta-analysis of case-control studies
  publication-title: PLoS One
– volume: 32
  start-page: 493
  year: 2016
  end-page: 503
  ident: bib2
  article-title: Evaluating extent of resection in pediatric glioblastoma: a multiple propensity score-adjusted population-based analysis
  publication-title: Childs Nerv. Syst.
– volume: 23
  start-page: 990
  year: 2021
  end-page: 998
  ident: bib82
  article-title: Epidemiology of brainstem high-grade gliomas in children and adolescents in the United States, 2000-2017
  publication-title: Neuro Oncol.
– volume: 41
  start-page: 35
  year: 2022
  ident: bib7
  article-title: Immunotherapy for glioblastoma: the promise of combination strategies
  publication-title: J. Exp. Clin. Cancer Res
– volume: 23
  start-page: 1985
  year: 2014
  end-page: 1996
  ident: bib101
  article-title: Epidemiologic and molecular prognostic review of glioblastoma
  publication-title: Cancer Epidemiol. Biomark. Prev.
– volume: 3
  start-page: 255
  year: 1993
  end-page: 268
  ident: bib49
  article-title: The new WHO classification of brain tumours
  publication-title: Brain Pathol.
– volume: 15
  start-page: 145
  year: 2020
  ident: bib103
  article-title: Survival after hypofractionation in glioblastoma: a systematic review and meta-analysis
  publication-title: Radiat. Oncol.
– volume: 32
  start-page: 21
  year: 2009
  end-page: 29
  ident: bib116
  article-title: Promoter methylation and polymorphisms of the MGMT gene in glioblastomas: a population-based study
  publication-title: Neuroepidemiology
– volume: 71
  start-page: 1093
  year: 2011
  end-page: 1104
  ident: bib15
  article-title: Ipilimumab: first global approval
  publication-title: Drugs
– volume: 104
  start-page: 1251
  year: 2012
  end-page: 1259
  ident: bib91
  article-title: Association between prediagnostic IgE levels and risk of glioma
  publication-title: J. Natl. Cancer Inst.
– volume: 92
  start-page: 913
  year: 2005
  end-page: 920
  ident: bib89
  article-title: Characteristics of CD4+CD25+ regulatory T cells in the peripheral circulation of patients with head and neck cancer
  publication-title: Br. J. Cancer
– volume: 11
  year: 2021
  ident: bib46
  article-title: Identification of gender-specific molecular differences in glioblastoma (GBM) and low-grade glioma (LGG) by the analysis of large transcriptomic and epigenomic datasets
  publication-title: Front. Oncol.
– volume: 162
  year: 2021
  ident: bib14
  article-title: Sexual differentiation specifies cellular responses to DNA damage
  publication-title: Endocrinology
– volume: 23
  start-page: 1231
  year: 2021
  end-page: 1251
  ident: bib61
  article-title: The 2021 WHO classification of tumors of the central nervous system: a summary
  publication-title: Neuro Oncol.
– volume: 24
  start-page: i82
  year: 2022
  end-page: i83
  ident: bib28
  article-title: Nivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: efficacy, safety, biomarker, and pharmacokinetic results from Checkmate 908
  publication-title: Neuro-Oncol.
– volume: 26
  start-page: 5232
  year: 2020
  end-page: 5245
  ident: bib53
  article-title: Advanced age increases immunosuppression in the brain and decreases immunotherapeutic efficacy in subjects with glioblastoma
  publication-title: Clin. Cancer Res.
– volume: 11
  start-page: 19493
  year: 2021
  ident: bib115
  article-title: Cell aging related genes can be used to characterize clinical prognoses and further stratify diffuse gliomas
  publication-title: Sci. Rep.
– volume: 25
  start-page: 477
  year: 2019
  end-page: 486
  ident: bib19
  article-title: Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma
  publication-title: Nat. Med.
– volume: 155
  start-page: 462
  year: 2013
  end-page: 477
  ident: bib12
  article-title: The somatic genomic landscape of glioblastoma
  publication-title: Cell
– volume: 5
  start-page: e9
  year: 2015
  end-page: e16
  ident: bib68
  article-title: Long-term survival after treatment of glioblastoma multiforme with hyperfractionated concomitant boost proton beam therapy
  publication-title: Pract. Radiat. Oncol.
– volume: 91
  start-page: 251
  year: 1999
  end-page: 260
  ident: bib33
  article-title: Accelerated fractionated proton/photon irradiation to 90 cobalt gray equivalent for glioblastoma multiforme: results of a phase II prospective trial
  publication-title: J. Neurosurg.
– volume: 12
  start-page: 1322
  year: 2013
  end-page: 1331
  ident: bib1
  article-title: Regorafenib inhibits growth, angiogenesis, and metastasis in a highly aggressive, orthotopic colon cancer model
  publication-title: Mol. Cancer Ther.
– volume: 106
  start-page: 260
  year: 2003
  end-page: 263
  ident: bib65
  article-title: Familial brain tumours-genetics or environment? A nationwide cohort study of cancer risk in spouses and first-degree relatives of brain tumour patients
  publication-title: Int. J. Cancer
– volume: 89
  start-page: 52
  year: 1998
  end-page: 59
  ident: bib109
  article-title: Current neurosurgical management and the impact of the extent of resection in the treatment of malignant gliomas of childhood: a report of the Children's Cancer Group trial no. CCG-945
  publication-title: J. Neurosurg.
– volume: 68
  start-page: 394
  year: 2018
  end-page: 424
  ident: bib11
  article-title: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
  publication-title: CA Cancer J. Clin.
– volume: 13
  start-page: 7223
  year: 2022
  ident: bib107
  article-title: Genomic disparities between cancers in adolescent and young adults and in older adults
  publication-title: Nat. Commun.
– volume: 6
  start-page: 1003
  year: 2020
  end-page: 1010
  ident: bib86
  article-title: Effect of nivolumab vs bevacizumab in patients with recurrent glioblastoma: the checkmate 143 phase 3 randomized clinical trial
  publication-title: JAMA Oncol.
– volume: 1
  start-page: 145
  year: 2014
  end-page: 157
  ident: bib105
  article-title: Management of high-grade gliomas in the pediatric patient: Past, present, and future
  publication-title: Neurooncol. Pract.
– volume: 83
  start-page: 76
  year: 2018
  end-page: 85
  ident: bib29
  article-title: Thalamic glioblastoma: clinical presentation, management strategies, and outcomes
  publication-title: Neurosurgery
– volume: 20
  start-page: 945
  year: 2009
  end-page: 955
  ident: bib57
  article-title: Maternal occupational exposure to extremely low frequency magnetic fields and the risk of brain cancer in the offspring
  publication-title: Cancer Causes Control
– year: 2022
  ident: bib44
  article-title: Glioblastoma Multiforme
– volume: 67
  year: 2020
  ident: bib96
  article-title: A phase 2 study of valproic acid and radiation, followed by maintenance valproic acid and bevacizumab in children with newly diagnosed diffuse intrinsic pontine glioma or high-grade glioma
  publication-title: Pedia Blood Cancer
– volume: 3
  year: 2021
  ident: bib48
  article-title: Glioblastoma as an age-related neurological disorder in adults
  publication-title: Neurooncol. Adv.
– volume: 211
  start-page: 45
  year: 2018
  end-page: 56
  ident: bib30
  article-title: Regorafenib
  publication-title: Recent Results Cancer Res.
– volume: 20
  start-page: 576
  year: 2018
  end-page: 577
  ident: bib75
  article-title: Females have the survival advantage in glioblastoma
  publication-title: Neuro Oncol.
– volume: 11
  year: 2019
  ident: bib113
  article-title: Sex differences in GBM revealed by analysis of patient imaging, transcriptome, and survival data
  publication-title: Sci. Transl. Med.
– volume: 19
  start-page: 764
  year: 2013
  end-page: 772
  ident: bib72
  article-title: The definition of primary and secondary glioblastoma
  publication-title: Clin. Cancer Res.
– reference: Das, K.K. and R. Kumar (2017). Pediatric Glioblastoma. Glioblastoma. S. De Vleeschouwer. Brisbane (AU).
– volume: 146
  start-page: 63
  year: 2020
  end-page: 69
  ident: bib6
  article-title: Delay in diagnosing patients with right-sided glioblastoma induced by hemispheric-specific clinical presentation
  publication-title: J. Neurooncol
– volume: 58
  start-page: 110
  year: 2018
  end-page: 115
  ident: bib27
  article-title: Prognostic factors in glioblastoma: is there a role for epilepsy?
  publication-title: Neurol. Med. Chir.
– volume: 11
  year: 2020
  ident: bib41
  article-title: Current immunotherapies for glioblastoma multiforme
  publication-title: Front. Immunol.
– volume: 65
  start-page: S14
  year: 2022
  end-page: S23
  ident: bib87
  article-title: A review of adult-type diffuse gliomas in the WHO CNS5 classification with special reference to Astrocytoma, IDH-mutant and Oligodendroglioma, IDH-mutant and 1p/19q codeleted
  publication-title: Indian J. Pathol. Microbiol.
– volume: 12
  start-page: 197
  year: 2012
  end-page: 209
  ident: bib100
  article-title: Targeting EGFR for treatment of glioblastoma: molecular basis to overcome resistance
  publication-title: Curr. Cancer Drug Targets
– volume: 160
  start-page: 978
  year: 2012
  end-page: 983
  ident: bib32
  article-title: Cancer in children with nonchromosomal birth defects
  publication-title: J. Pedia
– volume: 2
  start-page: 17040
  year: 2017
  ident: bib83
  article-title: Targeting cellular pathways in glioblastoma multiforme
  publication-title: Signal Transduct. Target. Ther.
– volume: 352
  start-page: 987
  year: 2005
  end-page: 996
  ident: bib95
  article-title: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
  publication-title: New Engl. J. Med.
– volume: 22
  start-page: 1805
  year: 2017
  end-page: 1829
  ident: bib111
  article-title: The roles of microglia/macrophages in tumor progression of brain cancer and metastatic disease
  publication-title: Front. Biosci.
– volume: 126
  start-page: 3255
  year: 2020
  end-page: 3264
  ident: bib85
  article-title: Optimal timing of chemoradiotherapy after surgical resection of glioblastoma: Stratification by validated prognostic classification
  publication-title: Cancer
– volume: 288
  start-page: 6127
  year: 2021
  end-page: 6141
  ident: bib17
  article-title: Pediatric high-grade glioma: moving toward subtype-specific multimodal therapy
  publication-title: FEBS J.
– volume: 20
  start-page: 110
  year: 2019
  end-page: 119
  ident: bib58
  article-title: Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial
  publication-title: Lancet Oncol.
– volume: 26
  start-page: 569
  year: 2016
  end-page: 580
  ident: bib94
  article-title: Diffuse midline gliomas with histone H3-K27M mutation: a series of 47 cases assessing the spectrum of morphologic variation and associated genetic alterations
  publication-title: Brain Pathol.
– volume: 159
  start-page: 1109
  year: 2004
  end-page: 1116
  ident: bib21
  article-title: Parental exposure to polycyclic aromatic hydrocarbons and the risk of childhood brain tumors: The SEARCH International Childhood Brain Tumor Study
  publication-title: Am. J. Epidemiol.
– volume: 140
  start-page: 329
  year: 2018
  end-page: 339
  ident: bib88
  article-title: Characteristics and outcomes of elderly patients with diffuse gliomas: a multi-institutional cohort study by Kansai molecular diagnosis network for CNS tumors
  publication-title: J. Neurooncol.
– volume: 113
  start-page: 5480
  year: 2009
  end-page: 5487
  ident: bib5
  article-title: Quantifying the development of the peripheral naive CD4+ T-cell pool in humans
  publication-title: Blood
– volume: 23
  year: 2021
  ident: bib79
  article-title: CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2014-2018
  publication-title: Neuro Oncol.
– volume: 163
  start-page: 1895
  year: 2021
  end-page: 1905
  ident: bib36
  article-title: Survival of glioblastoma in relation to tumor location: a statistical tumor atlas of a population-based cohort
  publication-title: Acta Neurochir.
– volume: 21
  start-page: v1
  year: 2019
  end-page: v100
  ident: bib77
  article-title: CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012-2016
  publication-title: Neuro Oncol.
– volume: 21
  start-page: 1357
  year: 2019
  end-page: 1375
  ident: bib78
  article-title: Risk factors for childhood and adult primary brain tumors
  publication-title: Neuro Oncol.
– volume: 143
  start-page: 2359
  year: 2018
  end-page: 2366
  ident: bib76
  article-title: Age-specific genome-wide association study in glioblastoma identifies increased proportion of 'lower grade glioma'-like features associated with younger age
  publication-title: Int. J. Cancer
– volume: 9
  year: 2019
  ident: bib80
  article-title: The usefulness of symptoms alone or combined for general practitioners in considering the diagnosis of a brain tumour: a case-control study using the clinical practice research database (CPRD) (2000-2014)
  publication-title: BMJ Open
– volume: 116
  start-page: 705
  year: 2010
  end-page: 712
  ident: bib110
  article-title: Intensive chemotherapy improves survival in pediatric high-grade glioma after gross total resection: results of the HIT-GBM-C protocol
  publication-title: Cancer
– volume: 21
  start-page: 2683
  year: 2007
  end-page: 2710
  ident: bib35
  article-title: Malignant astrocytic glioma: genetics, biology, and paths to treatment
  publication-title: Genes Dev.
– volume: 6
  start-page: 12
  year: 2018
  ident: bib45
  article-title: Cooperative p16 and p21 action protects female astrocytes from transformation
  publication-title: Acta Neuropathol. Commun.
– volume: 57
  start-page: 343
  year: 2017
  end-page: 355
  ident: bib69
  article-title: Proton beam therapy for pediatric brain tumor
  publication-title: Neurol. Med. Chir.
– volume: 28
  start-page: 2055
  year: 2012
  end-page: 2062
  ident: bib23
  article-title: Pediatric glioblastoma: clinico-radiological profile and factors affecting the outcome
  publication-title: Childs Nerv. Syst.
– volume: 36
  start-page: 951
  year: 2018
  end-page: 958
  ident: bib39
  article-title: Phase II, open-label, randomized, multicenter trial (HERBY) of bevacizumab in pediatric patients with newly diagnosed high-grade glioma
  publication-title: J. Clin. Oncol.
– volume: 129
  start-page: 245
  year: 2011
  end-page: 255
  ident: bib108
  article-title: Regorafenib (BAY 73-4506): a new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity
  publication-title: Int. J. Cancer
– volume: 124
  start-page: 4123
  year: 2014
  end-page: 4133
  ident: bib97
  article-title: Sexually dimorphic RB inactivation underlies mesenchymal glioblastoma prevalence in males
  publication-title: J. Clin. Invest
– volume: 67
  start-page: 139
  year: 2008
  end-page: 152
  ident: bib10
  article-title: Glioblastoma in adults
  publication-title: Crit. Rev. Oncol. Hematol.
– volume: 482
  start-page: 226
  year: 2012
  end-page: 231
  ident: bib92
  article-title: Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
  publication-title: Nature
– volume: 7
  start-page: 51
  year: 2018
  end-page: 65
  ident: bib93
  article-title: Contemporary management of high-grade gliomas
  publication-title: CNS Oncol.
– volume: 32
  start-page: 97
  year: 2016
  end-page: 103
  ident: bib70
  article-title: Pediatric glioblastoma: a single institution experience
  publication-title: Childs Nerv. Syst.
– volume: 27
  start-page: 93
  year: 2016
  end-page: 104
  ident: bib81
  article-title: Common mutations in ALK2/ACVR1, a multi-faceted receptor, have roles in distinct pediatric musculoskeletal and neural orphan disorders
  publication-title: Cytokine Growth Factor Rev.
– volume: 11
  start-page: 40
  year: 2020
  ident: bib114
  article-title: Comparative efficacy and safety of nivolumab and nivolumab plus ipilimumab in advanced cancer: a systematic review and meta-analysis
  publication-title: Front Pharmacol.
– volume: 140
  start-page: 485
  year: 2018
  end-page: 496
  ident: bib62
  article-title: Prevalence of symptoms in glioma patients throughout the disease trajectory: a systematic review
  publication-title: J. Neurooncol.
– volume: 18
  start-page: 3
  year: 2017
  end-page: 9
  ident: bib40
  article-title: Glioblastoma multiforme: a review of its epidemiology and pathogenesis through clinical presentation and treatment
  publication-title: Asian Pac. J. Cancer Prev.
– volume: 178
  start-page: 6465
  year: 2007
  end-page: 6475
  ident: bib64
  article-title: Peritoneal cell-derived mast cells: an in vitro model of mature serosal-type mouse mast cells
  publication-title: J. Immunol.
– volume: 70
  start-page: 299
  year: 2020
  end-page: 312
  ident: bib99
  article-title: Management of glioblastoma: state of the art and future directions
  publication-title: CA Cancer J. Clin.
– volume: 140
  start-page: 1757
  year: 2017
  end-page: 1769
  ident: bib4
  article-title: Factors related to pregnancy and birth and the risk of childhood brain tumours: The ESTELLE and ESCALE studies (SFCE, France)
  publication-title: Int. J. Cancer
– volume: 8
  start-page: 7352
  year: 2018
  ident: bib74
  article-title: Sex-specific glioma genome-wide association study identifies new risk locus at 3p21.31 in females, and finds sex-differences in risk at 8q24.21
  publication-title: Sci. Rep.
– volume: 132
  start-page: 2975
  year: 2013
  end-page: 2979
  ident: bib84
  article-title: Parental occupational exposure to engine exhausts and childhood brain tumors
  publication-title: Int J. Cancer
– volume: 13
  start-page: 112
  year: 1995
  end-page: 123
  ident: bib31
  article-title: Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Childrens cancer group
  publication-title: J. Clin. Oncol.
– year: 2017
  ident: bib98
  article-title: Epidemiology and outcome of glioblastoma
  publication-title: Glioblastoma
– volume: 73
  year: 2021
  ident: bib3
  article-title: Glioblastoma in adolescents and young adults: an age-based comparative study from Jordan over a 17-year period
  publication-title: Cancer Epidemiol.
– volume: 131
  start-page: 803
  year: 2016
  end-page: 820
  ident: bib60
  article-title: The 2016 World Health Organization classification of tumors of the central nervous system: a summary
  publication-title: Acta Neuropathol.
– reference: (5): 510–522.
– volume: 77
  start-page: 98
  year: 2010
  end-page: 105
  ident: bib67
  article-title: Phase I/II trial of hyperfractionated concomitant boost proton radiotherapy for supratentorial glioblastoma multiforme
  publication-title: Int J. Radiat. Oncol. Biol. Phys.
– volume: 126
  start-page: 1249
  year: 2021
  end-page: 1254
  ident: bib26
  article-title: Bevacizumab in recurrent high-grade glioma: a single institution retrospective analysis on 92 patients
  publication-title: Radiol. Med.
– volume: 37
  start-page: 50
  year: 2020
  end-page: 59
  ident: bib34
  article-title: Molecular characteristics and clinical outcomes of elderly patients with IDH-wildtype glioblastomas: comparative study of older and younger cases in Kansai Network cohort
  publication-title: Brain Tumor Pathol.
– volume: 124
  start-page: 439
  year: 2012
  end-page: 447
  ident: bib47
  article-title: K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas
  publication-title: Acta Neuropathol.
– reference: Noushmehr, H., D.J. Weisenberger, K. Diefes, H.S. Phillips, K. Pujara, B.P. Berman, F. Pan, C.E. Pelloski, E.P. Sulman, K.P. Bhat, R.G. Verhaak, K.A. Hoadley, D.N. Hayes, C.M. Perou, H.K. Schmidt, L. Ding, R.K. Wilson, D. Van Den Berg, H. Shen, H. Bengtsson, P. Neuvial, L.M. Cope, J. Buckley, J.G. Herman, S.B. Baylin, P.W. Laird, K. Aldape and N. Cancer Genome Atlas Research (2010). "Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma." Cancer Cell
– volume: 25
  start-page: 283
  year: 2014
  end-page: 291
  ident: bib38
  article-title: Exposure to household painting and floor treatments, and parental occupational paint exposure and risk of childhood brain tumors: results from an Australian case-control study
  publication-title: Cancer Causes Control
– volume: 177
  start-page: 63
  year: 2019
  end-page: 67
  ident: bib54
  article-title: Allergy may confer better survival on patients with gliomas
  publication-title: Clin. Neurol. Neurosurg.
– volume: 51
  start-page: 533
  year: 2015
  end-page: 542
  ident: bib13
  article-title: Glioblastoma in England: 2007-2011
  publication-title: Eur. J. Cancer
– volume: 32
  start-page: 520
  year: 2017
  end-page: 537
  ident: bib63
  article-title: Integrated molecular meta-analysis of 1,000 pediatric high-grade and diffuse intrinsic pontine glioma
  publication-title: Cancer Cell
– volume: 13
  start-page: 317
  year: 2011
  end-page: 323
  ident: bib20
  article-title: Temozolomide in the treatment of high-grade gliomas in children: a report from the Children's Oncology Group
  publication-title: Neuro Oncol.
– volume: 11
  year: 2019
  ident: bib22
  article-title: Pathological and molecular features of glioblastoma and its peritumoral tissue
  publication-title: Cancers
– volume: 6
  start-page: pl1
  year: 2013
  ident: bib37
  article-title: Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal
  publication-title: Sci. Signal.
– volume: 129
  start-page: 669
  year: 2015
  end-page: 678
  ident: bib51
  article-title: Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markers
  publication-title: Acta Neuropathol.
– volume: 112
  start-page: e407
  year: 2018
  end-page: e414
  ident: bib56
  article-title: Correlation between tumor location and clinical properties of glioblastomas in frontal and temporal lobes
  publication-title: World Neurosurg.
– volume: 16
  start-page: 240
  year: 2021
  ident: bib50
  article-title: Glioblastoma radiotherapy using Intensity modulated Radiotherapy (IMRT) or proton Radiotherapy-GRIPS Trial (Glioblastoma Radiotherapy via IMRT or Proton BeamS): a study protocol for a multicenter, prospective, open-label, randomized, two-arm, phase III study
  publication-title: Radiat. Oncol.
– volume: 10
  start-page: 200
  year: 2019
  ident: bib52
  article-title: The coincidence between increasing age, immunosuppression, and the incidence of patients with glioblastoma
  publication-title: Front. Pharmacol.
– volume: 21
  start-page: 39
  year: 2022
  ident: bib112
  article-title: Glioma targeted therapy: insight into future of molecular approaches
  publication-title: Mol. Cancer
– volume: 73
  start-page: 699
  year: 2009
  end-page: 708
  ident: bib104
  article-title: Phase I three-dimensional conformal radiation dose escalation study in newly diagnosed glioblastoma: radiation therapy oncology group trial 98-03
  publication-title: Int J. Radiat. Oncol. Biol. Phys.
– volume: 374
  start-page: n1560
  year: 2021
  ident: bib66
  article-title: Glioblastoma: clinical presentation, diagnosis, and management
  publication-title: BMJ
– volume: 104
  start-page: 2798
  year: 2005
  end-page: 2806
  ident: bib16
  article-title: A population-based description of glioblastoma multiforme in Los Angeles County, 1974-1999
  publication-title: Cancer
– volume: 129
  start-page: 453
  year: 2016
  end-page: 460
  ident: bib9
  article-title: Pembrolizumab: first experience with recurrent primary central nervous system (CNS) tumors
  publication-title: J Neurooncol
– volume: 13
  start-page: 507
  year: 2014
  end-page: 513
  ident: bib18
  article-title: Preoperative neuropsychological and behavioral evaluation of children with thalamic tumors
  publication-title: J. Neurosurg. Pedia
– volume: 12
  start-page: 34
  year: 2016
  end-page: 40
  ident: bib8
  article-title: Population-based MRI atlases of spatial distribution are specific to patient and tumor characteristics in glioblastoma
  publication-title: Neuroimage Clin.
– volume: 130
  start-page: 1
  year: 2017
  end-page: 6
  ident: bib102
  article-title: Epileptic features and survival in glioblastomas presenting with seizures
  publication-title: Epilepsy Res.
– volume: 18
  start-page: 1518
  year: 2012
  end-page: 1524
  ident: bib55
  article-title: Decline in miR-181a expression with age impairs T cell receptor sensitivity by increasing DUSP6 activity
  publication-title: Nat. Med.
– volume: 143
  start-page: 87
  year: 2019
  end-page: 93
  ident: bib90
  article-title: Incidence and clinicopathologic features of H3 K27M mutations in adults with radiographically-determined midline gliomas
  publication-title: J. Neurooncol.
– volume: 18
  start-page: v1
  year: 2016
  end-page: v75
  ident: bib73
  article-title: CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2009-2013
  publication-title: Neuro Oncol.
– volume: 10
  year: 2015
  ident: bib25
  article-title: Regorafenib: antitumor activity upon mono and combination therapy in preclinical pediatric malignancy models
  publication-title: PLoS One
– volume: 13
  year: 2021
  ident: bib59
  article-title: Regorafenib in recurrent glioblastoma patients: a large and monocentric real-life study
  publication-title: Cancers
– volume: 49
  start-page: 333
  year: 1978
  end-page: 343
  ident: bib106
  article-title: Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial
  publication-title: J. Neurosurg.
– volume: 5
  start-page: 102
  year: 2012
  end-page: 114
  ident: bib117
  article-title: "Temozolomide: mechanisms of action, repair and resistance."
  publication-title: Curr. Mol. Pharm.
– volume: 2
  start-page: 386
  year: 2009
  end-page: 393
  ident: bib42
  article-title: Current data and strategy in glioblastoma multiforme
  publication-title: J. Med. Life
– volume: 482
  start-page: 226
  issue: 7384
  year: 2012
  ident: 10.1016/j.mad.2023.111801_bib92
  article-title: Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
  publication-title: Nature
  doi: 10.1038/nature10833
– volume: 41
  start-page: 35
  issue: 1
  year: 2022
  ident: 10.1016/j.mad.2023.111801_bib7
  article-title: Immunotherapy for glioblastoma: the promise of combination strategies
  publication-title: J. Exp. Clin. Cancer Res
  doi: 10.1186/s13046-022-02251-2
– volume: 8
  start-page: 7352
  issue: 1
  year: 2018
  ident: 10.1016/j.mad.2023.111801_bib74
  article-title: Sex-specific glioma genome-wide association study identifies new risk locus at 3p21.31 in females, and finds sex-differences in risk at 8q24.21
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-018-24580-z
– volume: 58
  start-page: 110
  issue: 3
  year: 2018
  ident: 10.1016/j.mad.2023.111801_bib27
  article-title: Prognostic factors in glioblastoma: is there a role for epilepsy?
  publication-title: Neurol. Med. Chir.
  doi: 10.2176/nmc.oa.2017-0167
– volume: 131
  start-page: 803
  issue: 6
  year: 2016
  ident: 10.1016/j.mad.2023.111801_bib60
  article-title: The 2016 World Health Organization classification of tumors of the central nervous system: a summary
  publication-title: Acta Neuropathol.
  doi: 10.1007/s00401-016-1545-1
– volume: 374
  start-page: n1560
  year: 2021
  ident: 10.1016/j.mad.2023.111801_bib66
  article-title: Glioblastoma: clinical presentation, diagnosis, and management
  publication-title: BMJ
  doi: 10.1136/bmj.n1560
– volume: 7
  start-page: 51
  issue: 1
  year: 2018
  ident: 10.1016/j.mad.2023.111801_bib93
  article-title: Contemporary management of high-grade gliomas
  publication-title: CNS Oncol.
  doi: 10.2217/cns-2017-0026
– volume: 21
  start-page: v1
  issue: 5
  year: 2019
  ident: 10.1016/j.mad.2023.111801_bib77
  article-title: CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012-2016
  publication-title: Neuro Oncol.
  doi: 10.1093/neuonc/noz150
– volume: 162
  issue: 11
  year: 2021
  ident: 10.1016/j.mad.2023.111801_bib14
  article-title: Sexual differentiation specifies cellular responses to DNA damage
  publication-title: Endocrinology
  doi: 10.1210/endocr/bqab192
– volume: 65
  start-page: S14
  year: 2022
  ident: 10.1016/j.mad.2023.111801_bib87
  article-title: A review of adult-type diffuse gliomas in the WHO CNS5 classification with special reference to Astrocytoma, IDH-mutant and Oligodendroglioma, IDH-mutant and 1p/19q codeleted
  publication-title: Indian J. Pathol. Microbiol.
– volume: 352
  start-page: 987
  issue: 10
  year: 2005
  ident: 10.1016/j.mad.2023.111801_bib95
  article-title: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
  publication-title: New Engl. J. Med.
  doi: 10.1056/NEJMoa043330
– volume: 9
  issue: 8
  year: 2019
  ident: 10.1016/j.mad.2023.111801_bib80
  article-title: The usefulness of symptoms alone or combined for general practitioners in considering the diagnosis of a brain tumour: a case-control study using the clinical practice research database (CPRD) (2000-2014)
  publication-title: BMJ Open
  doi: 10.1136/bmjopen-2019-029686
– volume: 3
  start-page: 255
  issue: 3
  year: 1993
  ident: 10.1016/j.mad.2023.111801_bib49
  article-title: The new WHO classification of brain tumours
  publication-title: Brain Pathol.
  doi: 10.1111/j.1750-3639.1993.tb00752.x
– volume: 26
  start-page: 5232
  issue: 19
  year: 2020
  ident: 10.1016/j.mad.2023.111801_bib53
  article-title: Advanced age increases immunosuppression in the brain and decreases immunotherapeutic efficacy in subjects with glioblastoma
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-19-3874
– volume: 124
  start-page: 439
  issue: 3
  year: 2012
  ident: 10.1016/j.mad.2023.111801_bib47
  article-title: K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas
  publication-title: Acta Neuropathol.
  doi: 10.1007/s00401-012-0998-0
– volume: 155
  start-page: 462
  issue: 2
  year: 2013
  ident: 10.1016/j.mad.2023.111801_bib12
  article-title: The somatic genomic landscape of glioblastoma
  publication-title: Cell
  doi: 10.1016/j.cell.2013.09.034
– year: 2017
  ident: 10.1016/j.mad.2023.111801_bib98
  article-title: Epidemiology and outcome of glioblastoma
– volume: 8
  issue: 1
  year: 2013
  ident: 10.1016/j.mad.2023.111801_bib43
  article-title: Association between the XRCC1 polymorphisms and glioma risk: a meta-analysis of case-control studies
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0055597
– volume: 5
  start-page: e9
  issue: 1
  year: 2015
  ident: 10.1016/j.mad.2023.111801_bib68
  article-title: Long-term survival after treatment of glioblastoma multiforme with hyperfractionated concomitant boost proton beam therapy
  publication-title: Pract. Radiat. Oncol.
  doi: 10.1016/j.prro.2014.03.012
– volume: 16
  start-page: 240
  issue: 1
  year: 2021
  ident: 10.1016/j.mad.2023.111801_bib50
  publication-title: Radiat. Oncol.
  doi: 10.1186/s13014-021-01962-8
– volume: 140
  start-page: 329
  issue: 2
  year: 2018
  ident: 10.1016/j.mad.2023.111801_bib88
  article-title: Characteristics and outcomes of elderly patients with diffuse gliomas: a multi-institutional cohort study by Kansai molecular diagnosis network for CNS tumors
  publication-title: J. Neurooncol.
  doi: 10.1007/s11060-018-2957-7
– volume: 91
  start-page: 251
  issue: 2
  year: 1999
  ident: 10.1016/j.mad.2023.111801_bib33
  article-title: Accelerated fractionated proton/photon irradiation to 90 cobalt gray equivalent for glioblastoma multiforme: results of a phase II prospective trial
  publication-title: J. Neurosurg.
  doi: 10.3171/jns.1999.91.2.0251
– volume: 132
  start-page: 2975
  issue: 12
  year: 2013
  ident: 10.1016/j.mad.2023.111801_bib84
  article-title: Parental occupational exposure to engine exhausts and childhood brain tumors
  publication-title: Int J. Cancer
  doi: 10.1002/ijc.27972
– volume: 5
  start-page: 102
  issue: 1
  year: 2012
  ident: 10.1016/j.mad.2023.111801_bib117
  article-title: "Temozolomide: mechanisms of action, repair and resistance."
  publication-title: Curr. Mol. Pharm.
  doi: 10.2174/1874467211205010102
– volume: 13
  start-page: 112
  issue: 1
  year: 1995
  ident: 10.1016/j.mad.2023.111801_bib31
  article-title: Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Childrens cancer group
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.1995.13.1.112
– volume: 112
  start-page: e407
  year: 2018
  ident: 10.1016/j.mad.2023.111801_bib56
  article-title: Correlation between tumor location and clinical properties of glioblastomas in frontal and temporal lobes
  publication-title: World Neurosurg.
  doi: 10.1016/j.wneu.2018.01.055
– volume: 23
  issue: 2
  year: 2021
  ident: 10.1016/j.mad.2023.111801_bib79
  article-title: CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2014-2018
  publication-title: Neuro Oncol.
– volume: 11
  year: 2021
  ident: 10.1016/j.mad.2023.111801_bib46
  article-title: Identification of gender-specific molecular differences in glioblastoma (GBM) and low-grade glioma (LGG) by the analysis of large transcriptomic and epigenomic datasets
  publication-title: Front. Oncol.
  doi: 10.3389/fonc.2021.699594
– volume: 77
  start-page: 98
  issue: 1
  year: 2010
  ident: 10.1016/j.mad.2023.111801_bib67
  article-title: Phase I/II trial of hyperfractionated concomitant boost proton radiotherapy for supratentorial glioblastoma multiforme
  publication-title: Int J. Radiat. Oncol. Biol. Phys.
  doi: 10.1016/j.ijrobp.2009.04.054
– volume: 83
  start-page: 76
  issue: 1
  year: 2018
  ident: 10.1016/j.mad.2023.111801_bib29
  article-title: Thalamic glioblastoma: clinical presentation, management strategies, and outcomes
  publication-title: Neurosurgery
  doi: 10.1093/neuros/nyx349
– volume: 13
  issue: 18
  year: 2021
  ident: 10.1016/j.mad.2023.111801_bib59
  article-title: Regorafenib in recurrent glioblastoma patients: a large and monocentric real-life study
  publication-title: Cancers
  doi: 10.3390/cancers13184731
– volume: 37
  start-page: 50
  issue: 2
  year: 2020
  ident: 10.1016/j.mad.2023.111801_bib34
  article-title: Molecular characteristics and clinical outcomes of elderly patients with IDH-wildtype glioblastomas: comparative study of older and younger cases in Kansai Network cohort
  publication-title: Brain Tumor Pathol.
  doi: 10.1007/s10014-020-00363-1
– volume: 143
  start-page: 2359
  issue: 10
  year: 2018
  ident: 10.1016/j.mad.2023.111801_bib76
  article-title: Age-specific genome-wide association study in glioblastoma identifies increased proportion of 'lower grade glioma'-like features associated with younger age
  publication-title: Int. J. Cancer
  doi: 10.1002/ijc.31759
– volume: 32
  start-page: 97
  issue: 1
  year: 2016
  ident: 10.1016/j.mad.2023.111801_bib70
  article-title: Pediatric glioblastoma: a single institution experience
  publication-title: Childs Nerv. Syst.
  doi: 10.1007/s00381-015-2945-6
– volume: 57
  start-page: 343
  issue: 7
  year: 2017
  ident: 10.1016/j.mad.2023.111801_bib69
  article-title: Proton beam therapy for pediatric brain tumor
  publication-title: Neurol. Med. Chir.
  doi: 10.2176/nmc.ra.2017-0003
– volume: 288
  start-page: 6127
  issue: 21
  year: 2021
  ident: 10.1016/j.mad.2023.111801_bib17
  article-title: Pediatric high-grade glioma: moving toward subtype-specific multimodal therapy
  publication-title: FEBS J.
  doi: 10.1111/febs.15739
– volume: 13
  start-page: 317
  issue: 3
  year: 2011
  ident: 10.1016/j.mad.2023.111801_bib20
  article-title: Temozolomide in the treatment of high-grade gliomas in children: a report from the Children's Oncology Group
  publication-title: Neuro Oncol.
  doi: 10.1093/neuonc/noq191
– volume: 49
  start-page: 333
  issue: 3
  year: 1978
  ident: 10.1016/j.mad.2023.111801_bib106
  article-title: Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial
  publication-title: J. Neurosurg.
  doi: 10.3171/jns.1978.49.3.0333
– volume: 129
  start-page: 453
  year: 2016
  ident: 10.1016/j.mad.2023.111801_bib9
  article-title: Pembrolizumab: first experience with recurrent primary central nervous system (CNS) tumors
  publication-title: J Neurooncol
  doi: 10.1007/s11060-016-2190-1
– volume: 18
  start-page: v1
  issue: 5
  year: 2016
  ident: 10.1016/j.mad.2023.111801_bib73
  article-title: CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2009-2013
  publication-title: Neuro Oncol.
  doi: 10.1093/neuonc/now207
– volume: 12
  start-page: 34
  year: 2016
  ident: 10.1016/j.mad.2023.111801_bib8
  article-title: Population-based MRI atlases of spatial distribution are specific to patient and tumor characteristics in glioblastoma
  publication-title: Neuroimage Clin.
  doi: 10.1016/j.nicl.2016.03.007
– volume: 11
  year: 2020
  ident: 10.1016/j.mad.2023.111801_bib41
  article-title: Current immunotherapies for glioblastoma multiforme
  publication-title: Front. Immunol.
– ident: 10.1016/j.mad.2023.111801_bib71
  doi: 10.1016/j.ccr.2010.03.017
– volume: 11
  start-page: 40
  year: 2020
  ident: 10.1016/j.mad.2023.111801_bib114
  article-title: Comparative efficacy and safety of nivolumab and nivolumab plus ipilimumab in advanced cancer: a systematic review and meta-analysis
  publication-title: Front Pharmacol.
  doi: 10.3389/fphar.2020.00040
– volume: 68
  start-page: 394
  issue: 6
  year: 2018
  ident: 10.1016/j.mad.2023.111801_bib11
  article-title: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
  publication-title: CA Cancer J. Clin.
  doi: 10.3322/caac.21492
– volume: 67
  start-page: 139
  issue: 2
  year: 2008
  ident: 10.1016/j.mad.2023.111801_bib10
  article-title: Glioblastoma in adults
  publication-title: Crit. Rev. Oncol. Hematol.
  doi: 10.1016/j.critrevonc.2008.02.005
– volume: 32
  start-page: 21
  issue: 1
  year: 2009
  ident: 10.1016/j.mad.2023.111801_bib116
  article-title: Promoter methylation and polymorphisms of the MGMT gene in glioblastomas: a population-based study
  publication-title: Neuroepidemiology
  doi: 10.1159/000170088
– volume: 92
  start-page: 913
  issue: 5
  year: 2005
  ident: 10.1016/j.mad.2023.111801_bib89
  article-title: Characteristics of CD4+CD25+ regulatory T cells in the peripheral circulation of patients with head and neck cancer
  publication-title: Br. J. Cancer
  doi: 10.1038/sj.bjc.6602407
– volume: 23
  start-page: 990
  issue: 6
  year: 2021
  ident: 10.1016/j.mad.2023.111801_bib82
  article-title: Epidemiology of brainstem high-grade gliomas in children and adolescents in the United States, 2000-2017
  publication-title: Neuro Oncol.
  doi: 10.1093/neuonc/noaa295
– volume: 1
  start-page: 145
  issue: 4
  year: 2014
  ident: 10.1016/j.mad.2023.111801_bib105
  article-title: Management of high-grade gliomas in the pediatric patient: Past, present, and future
  publication-title: Neurooncol. Pract.
– volume: 124
  start-page: 4123
  issue: 9
  year: 2014
  ident: 10.1016/j.mad.2023.111801_bib97
  article-title: Sexually dimorphic RB inactivation underlies mesenchymal glioblastoma prevalence in males
  publication-title: J. Clin. Invest
  doi: 10.1172/JCI71048
– volume: 11
  start-page: 19493
  issue: 1
  year: 2021
  ident: 10.1016/j.mad.2023.111801_bib115
  article-title: Cell aging related genes can be used to characterize clinical prognoses and further stratify diffuse gliomas
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-021-98913-w
– year: 2022
  ident: 10.1016/j.mad.2023.111801_bib44
– volume: 10
  start-page: 200
  year: 2019
  ident: 10.1016/j.mad.2023.111801_bib52
  article-title: The coincidence between increasing age, immunosuppression, and the incidence of patients with glioblastoma
  publication-title: Front. Pharmacol.
  doi: 10.3389/fphar.2019.00200
– volume: 11
  issue: 473
  year: 2019
  ident: 10.1016/j.mad.2023.111801_bib113
  article-title: Sex differences in GBM revealed by analysis of patient imaging, transcriptome, and survival data
  publication-title: Sci. Transl. Med.
  doi: 10.1126/scitranslmed.aao5253
– volume: 126
  start-page: 1249
  issue: 9
  year: 2021
  ident: 10.1016/j.mad.2023.111801_bib26
  article-title: Bevacizumab in recurrent high-grade glioma: a single institution retrospective analysis on 92 patients
  publication-title: Radiol. Med.
  doi: 10.1007/s11547-021-01381-5
– volume: 126
  start-page: 3255
  issue: 14
  year: 2020
  ident: 10.1016/j.mad.2023.111801_bib85
  article-title: Optimal timing of chemoradiotherapy after surgical resection of glioblastoma: Stratification by validated prognostic classification
  publication-title: Cancer
  doi: 10.1002/cncr.32797
– volume: 13
  start-page: 7223
  issue: 1
  year: 2022
  ident: 10.1016/j.mad.2023.111801_bib107
  article-title: Genomic disparities between cancers in adolescent and young adults and in older adults
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-022-34959-2
– volume: 12
  start-page: 197
  issue: 3
  year: 2012
  ident: 10.1016/j.mad.2023.111801_bib100
  article-title: Targeting EGFR for treatment of glioblastoma: molecular basis to overcome resistance
  publication-title: Curr. Cancer Drug Targets
  doi: 10.2174/156800912799277557
– volume: 140
  start-page: 1757
  issue: 8
  year: 2017
  ident: 10.1016/j.mad.2023.111801_bib4
  article-title: Factors related to pregnancy and birth and the risk of childhood brain tumours: The ESTELLE and ESCALE studies (SFCE, France)
  publication-title: Int. J. Cancer
  doi: 10.1002/ijc.30597
– volume: 20
  start-page: 576
  issue: 4
  year: 2018
  ident: 10.1016/j.mad.2023.111801_bib75
  article-title: Females have the survival advantage in glioblastoma
  publication-title: Neuro Oncol.
  doi: 10.1093/neuonc/noy002
– volume: 28
  start-page: 2055
  issue: 12
  year: 2012
  ident: 10.1016/j.mad.2023.111801_bib23
  article-title: Pediatric glioblastoma: clinico-radiological profile and factors affecting the outcome
  publication-title: Childs Nerv. Syst.
  doi: 10.1007/s00381-012-1890-x
– volume: 177
  start-page: 63
  year: 2019
  ident: 10.1016/j.mad.2023.111801_bib54
  article-title: Allergy may confer better survival on patients with gliomas
  publication-title: Clin. Neurol. Neurosurg.
  doi: 10.1016/j.clineuro.2018.12.021
– volume: 146
  start-page: 63
  issue: 1
  year: 2020
  ident: 10.1016/j.mad.2023.111801_bib6
  article-title: Delay in diagnosing patients with right-sided glioblastoma induced by hemispheric-specific clinical presentation
  publication-title: J. Neurooncol
  doi: 10.1007/s11060-019-03335-4
– volume: 3
  issue: 1
  year: 2021
  ident: 10.1016/j.mad.2023.111801_bib48
  article-title: Glioblastoma as an age-related neurological disorder in adults
  publication-title: Neurooncol. Adv.
– volume: 25
  start-page: 477
  issue: 3
  year: 2019
  ident: 10.1016/j.mad.2023.111801_bib19
  article-title: Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma
  publication-title: Nat. Med.
  doi: 10.1038/s41591-018-0337-7
– volume: 10
  issue: 11
  year: 2015
  ident: 10.1016/j.mad.2023.111801_bib25
  article-title: Regorafenib: antitumor activity upon mono and combination therapy in preclinical pediatric malignancy models
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0142612
– volume: 18
  start-page: 3
  issue: 1
  year: 2017
  ident: 10.1016/j.mad.2023.111801_bib40
  article-title: Glioblastoma multiforme: a review of its epidemiology and pathogenesis through clinical presentation and treatment
  publication-title: Asian Pac. J. Cancer Prev.
– volume: 13
  start-page: 507
  issue: 5
  year: 2014
  ident: 10.1016/j.mad.2023.111801_bib18
  article-title: Preoperative neuropsychological and behavioral evaluation of children with thalamic tumors
  publication-title: J. Neurosurg. Pedia
  doi: 10.3171/2014.2.PEDS13352
– volume: 21
  start-page: 2683
  issue: 21
  year: 2007
  ident: 10.1016/j.mad.2023.111801_bib35
  article-title: Malignant astrocytic glioma: genetics, biology, and paths to treatment
  publication-title: Genes Dev.
  doi: 10.1101/gad.1596707
– volume: 71
  start-page: 1093
  issue: 8
  year: 2011
  ident: 10.1016/j.mad.2023.111801_bib15
  article-title: Ipilimumab: first global approval
  publication-title: Drugs
  doi: 10.2165/11594010-000000000-00000
– volume: 70
  start-page: 299
  issue: 4
  year: 2020
  ident: 10.1016/j.mad.2023.111801_bib99
  article-title: Management of glioblastoma: state of the art and future directions
  publication-title: CA Cancer J. Clin.
  doi: 10.3322/caac.21613
– volume: 12
  start-page: 1322
  issue: 7
  year: 2013
  ident: 10.1016/j.mad.2023.111801_bib1
  article-title: Regorafenib inhibits growth, angiogenesis, and metastasis in a highly aggressive, orthotopic colon cancer model
  publication-title: Mol. Cancer Ther.
  doi: 10.1158/1535-7163.MCT-12-1162
– volume: 32
  start-page: 493
  issue: 3
  year: 2016
  ident: 10.1016/j.mad.2023.111801_bib2
  article-title: Evaluating extent of resection in pediatric glioblastoma: a multiple propensity score-adjusted population-based analysis
  publication-title: Childs Nerv. Syst.
  doi: 10.1007/s00381-015-3006-x
– volume: 116
  start-page: 705
  issue: 3
  year: 2010
  ident: 10.1016/j.mad.2023.111801_bib110
  article-title: Intensive chemotherapy improves survival in pediatric high-grade glioma after gross total resection: results of the HIT-GBM-C protocol
  publication-title: Cancer
  doi: 10.1002/cncr.24730
– volume: 24
  start-page: i82
  year: 2022
  ident: 10.1016/j.mad.2023.111801_bib28
  article-title: Nivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: efficacy, safety, biomarker, and pharmacokinetic results from Checkmate 908
  publication-title: Neuro-Oncol.
  doi: 10.1093/neuonc/noac079.301
– volume: 2
  start-page: 386
  issue: 4
  year: 2009
  ident: 10.1016/j.mad.2023.111801_bib42
  article-title: Current data and strategy in glioblastoma multiforme
  publication-title: J. Med. Life
– volume: 32
  start-page: 520
  issue: 4
  year: 2017
  ident: 10.1016/j.mad.2023.111801_bib63
  article-title: Integrated molecular meta-analysis of 1,000 pediatric high-grade and diffuse intrinsic pontine glioma
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2017.08.017
– volume: 106
  start-page: 260
  issue: 2
  year: 2003
  ident: 10.1016/j.mad.2023.111801_bib65
  article-title: Familial brain tumours-genetics or environment? A nationwide cohort study of cancer risk in spouses and first-degree relatives of brain tumour patients
  publication-title: Int. J. Cancer
  doi: 10.1002/ijc.11213
– volume: 26
  start-page: 569
  issue: 5
  year: 2016
  ident: 10.1016/j.mad.2023.111801_bib94
  article-title: Diffuse midline gliomas with histone H3-K27M mutation: a series of 47 cases assessing the spectrum of morphologic variation and associated genetic alterations
  publication-title: Brain Pathol.
  doi: 10.1111/bpa.12336
– volume: 89
  start-page: 52
  issue: 1
  year: 1998
  ident: 10.1016/j.mad.2023.111801_bib109
  article-title: Current neurosurgical management and the impact of the extent of resection in the treatment of malignant gliomas of childhood: a report of the Children's Cancer Group trial no. CCG-945
  publication-title: J. Neurosurg.
  doi: 10.3171/jns.1998.89.1.0052
– volume: 2
  start-page: 17040
  year: 2017
  ident: 10.1016/j.mad.2023.111801_bib83
  article-title: Targeting cellular pathways in glioblastoma multiforme
  publication-title: Signal Transduct. Target. Ther.
  doi: 10.1038/sigtrans.2017.40
– volume: 18
  start-page: 1518
  issue: 10
  year: 2012
  ident: 10.1016/j.mad.2023.111801_bib55
  article-title: Decline in miR-181a expression with age impairs T cell receptor sensitivity by increasing DUSP6 activity
  publication-title: Nat. Med.
  doi: 10.1038/nm.2963
– volume: 211
  start-page: 45
  year: 2018
  ident: 10.1016/j.mad.2023.111801_bib30
  article-title: Regorafenib
  publication-title: Recent Results Cancer Res.
  doi: 10.1007/978-3-319-91442-8_3
– volume: 19
  start-page: 764
  issue: 4
  year: 2013
  ident: 10.1016/j.mad.2023.111801_bib72
  article-title: The definition of primary and secondary glioblastoma
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-12-3002
– volume: 6
  start-page: pl1
  issue: 269
  year: 2013
  ident: 10.1016/j.mad.2023.111801_bib37
  article-title: Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal
  publication-title: Sci. Signal.
  doi: 10.1126/scisignal.2004088
– volume: 20
  start-page: 110
  issue: 1
  year: 2019
  ident: 10.1016/j.mad.2023.111801_bib58
  article-title: Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial
  publication-title: Lancet Oncol.
  doi: 10.1016/S1470-2045(18)30675-2
– volume: 6
  start-page: 12
  issue: 1
  year: 2018
  ident: 10.1016/j.mad.2023.111801_bib45
  article-title: Cooperative p16 and p21 action protects female astrocytes from transformation
  publication-title: Acta Neuropathol. Commun.
  doi: 10.1186/s40478-018-0513-5
– volume: 27
  start-page: 93
  year: 2016
  ident: 10.1016/j.mad.2023.111801_bib81
  article-title: Common mutations in ALK2/ACVR1, a multi-faceted receptor, have roles in distinct pediatric musculoskeletal and neural orphan disorders
  publication-title: Cytokine Growth Factor Rev.
  doi: 10.1016/j.cytogfr.2015.12.007
– volume: 73
  start-page: 699
  issue: 3
  year: 2009
  ident: 10.1016/j.mad.2023.111801_bib104
  article-title: Phase I three-dimensional conformal radiation dose escalation study in newly diagnosed glioblastoma: radiation therapy oncology group trial 98-03
  publication-title: Int J. Radiat. Oncol. Biol. Phys.
  doi: 10.1016/j.ijrobp.2008.05.034
– volume: 113
  start-page: 5480
  issue: 22
  year: 2009
  ident: 10.1016/j.mad.2023.111801_bib5
  article-title: Quantifying the development of the peripheral naive CD4+ T-cell pool in humans
  publication-title: Blood
  doi: 10.1182/blood-2008-10-184184
– volume: 129
  start-page: 669
  issue: 5
  year: 2015
  ident: 10.1016/j.mad.2023.111801_bib51
  article-title: Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markers
  publication-title: Acta Neuropathol.
  doi: 10.1007/s00401-015-1405-4
– volume: 159
  start-page: 1109
  issue: 12
  year: 2004
  ident: 10.1016/j.mad.2023.111801_bib21
  article-title: Parental exposure to polycyclic aromatic hydrocarbons and the risk of childhood brain tumors: The SEARCH International Childhood Brain Tumor Study
  publication-title: Am. J. Epidemiol.
  doi: 10.1093/aje/kwh154
– ident: 10.1016/j.mad.2023.111801_bib24
– volume: 129
  start-page: 245
  issue: 1
  year: 2011
  ident: 10.1016/j.mad.2023.111801_bib108
  article-title: Regorafenib (BAY 73-4506): a new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity
  publication-title: Int. J. Cancer
  doi: 10.1002/ijc.25864
– volume: 163
  start-page: 1895
  issue: 7
  year: 2021
  ident: 10.1016/j.mad.2023.111801_bib36
  article-title: Survival of glioblastoma in relation to tumor location: a statistical tumor atlas of a population-based cohort
  publication-title: Acta Neurochir.
  doi: 10.1007/s00701-021-04802-6
– volume: 6
  start-page: 1003
  issue: 7
  year: 2020
  ident: 10.1016/j.mad.2023.111801_bib86
  article-title: Effect of nivolumab vs bevacizumab in patients with recurrent glioblastoma: the checkmate 143 phase 3 randomized clinical trial
  publication-title: JAMA Oncol.
  doi: 10.1001/jamaoncol.2020.1024
– volume: 178
  start-page: 6465
  issue: 10
  year: 2007
  ident: 10.1016/j.mad.2023.111801_bib64
  article-title: Peritoneal cell-derived mast cells: an in vitro model of mature serosal-type mouse mast cells
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.178.10.6465
– volume: 130
  start-page: 1
  year: 2017
  ident: 10.1016/j.mad.2023.111801_bib102
  article-title: Epileptic features and survival in glioblastomas presenting with seizures
  publication-title: Epilepsy Res.
  doi: 10.1016/j.eplepsyres.2016.12.013
– volume: 51
  start-page: 533
  issue: 4
  year: 2015
  ident: 10.1016/j.mad.2023.111801_bib13
  article-title: Glioblastoma in England: 2007-2011
  publication-title: Eur. J. Cancer
  doi: 10.1016/j.ejca.2014.12.014
– volume: 160
  start-page: 978
  issue: 6
  year: 2012
  ident: 10.1016/j.mad.2023.111801_bib32
  article-title: Cancer in children with nonchromosomal birth defects
  publication-title: J. Pedia
  doi: 10.1016/j.jpeds.2011.12.006
– volume: 23
  start-page: 1231
  issue: 8
  year: 2021
  ident: 10.1016/j.mad.2023.111801_bib61
  article-title: The 2021 WHO classification of tumors of the central nervous system: a summary
  publication-title: Neuro Oncol.
  doi: 10.1093/neuonc/noab106
– volume: 104
  start-page: 2798
  issue: 12
  year: 2005
  ident: 10.1016/j.mad.2023.111801_bib16
  article-title: A population-based description of glioblastoma multiforme in Los Angeles County, 1974-1999
  publication-title: Cancer
  doi: 10.1002/cncr.21539
– volume: 36
  start-page: 951
  issue: 10
  year: 2018
  ident: 10.1016/j.mad.2023.111801_bib39
  article-title: Phase II, open-label, randomized, multicenter trial (HERBY) of bevacizumab in pediatric patients with newly diagnosed high-grade glioma
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.2017.76.0611
– volume: 143
  start-page: 87
  issue: 1
  year: 2019
  ident: 10.1016/j.mad.2023.111801_bib90
  article-title: Incidence and clinicopathologic features of H3 K27M mutations in adults with radiographically-determined midline gliomas
  publication-title: J. Neurooncol.
  doi: 10.1007/s11060-019-03134-x
– volume: 140
  start-page: 485
  issue: 3
  year: 2018
  ident: 10.1016/j.mad.2023.111801_bib62
  article-title: Prevalence of symptoms in glioma patients throughout the disease trajectory: a systematic review
  publication-title: J. Neurooncol.
  doi: 10.1007/s11060-018-03015-9
– volume: 21
  start-page: 39
  issue: 1
  year: 2022
  ident: 10.1016/j.mad.2023.111801_bib112
  article-title: Glioma targeted therapy: insight into future of molecular approaches
  publication-title: Mol. Cancer
  doi: 10.1186/s12943-022-01513-z
– volume: 20
  start-page: 945
  issue: 6
  year: 2009
  ident: 10.1016/j.mad.2023.111801_bib57
  article-title: Maternal occupational exposure to extremely low frequency magnetic fields and the risk of brain cancer in the offspring
  publication-title: Cancer Causes Control
  doi: 10.1007/s10552-009-9311-5
– volume: 11
  issue: 4
  year: 2019
  ident: 10.1016/j.mad.2023.111801_bib22
  article-title: Pathological and molecular features of glioblastoma and its peritumoral tissue
  publication-title: Cancers
– volume: 25
  start-page: 283
  issue: 3
  year: 2014
  ident: 10.1016/j.mad.2023.111801_bib38
  article-title: Exposure to household painting and floor treatments, and parental occupational paint exposure and risk of childhood brain tumors: results from an Australian case-control study
  publication-title: Cancer Causes Control
  doi: 10.1007/s10552-013-0330-x
– volume: 73
  year: 2021
  ident: 10.1016/j.mad.2023.111801_bib3
  article-title: Glioblastoma in adolescents and young adults: an age-based comparative study from Jordan over a 17-year period
  publication-title: Cancer Epidemiol.
  doi: 10.1016/j.canep.2021.101948
– volume: 22
  start-page: 1805
  issue: 10
  year: 2017
  ident: 10.1016/j.mad.2023.111801_bib111
  article-title: The roles of microglia/macrophages in tumor progression of brain cancer and metastatic disease
  publication-title: Front. Biosci.
  doi: 10.2741/4573
– volume: 67
  issue: 6
  year: 2020
  ident: 10.1016/j.mad.2023.111801_bib96
  article-title: A phase 2 study of valproic acid and radiation, followed by maintenance valproic acid and bevacizumab in children with newly diagnosed diffuse intrinsic pontine glioma or high-grade glioma
  publication-title: Pedia Blood Cancer
  doi: 10.1002/pbc.28283
– volume: 21
  start-page: 1357
  issue: 11
  year: 2019
  ident: 10.1016/j.mad.2023.111801_bib78
  article-title: Risk factors for childhood and adult primary brain tumors
  publication-title: Neuro Oncol.
  doi: 10.1093/neuonc/noz123
– volume: 104
  start-page: 1251
  issue: 16
  year: 2012
  ident: 10.1016/j.mad.2023.111801_bib91
  article-title: Association between prediagnostic IgE levels and risk of glioma
  publication-title: J. Natl. Cancer Inst.
  doi: 10.1093/jnci/djs315
– volume: 15
  start-page: 145
  issue: 1
  year: 2020
  ident: 10.1016/j.mad.2023.111801_bib103
  article-title: Survival after hypofractionation in glioblastoma: a systematic review and meta-analysis
  publication-title: Radiat. Oncol.
  doi: 10.1186/s13014-020-01584-6
– volume: 23
  start-page: 1985
  issue: 10
  year: 2014
  ident: 10.1016/j.mad.2023.111801_bib101
  article-title: Epidemiologic and molecular prognostic review of glioblastoma
  publication-title: Cancer Epidemiol. Biomark. Prev.
  doi: 10.1158/1055-9965.EPI-14-0275
SSID ssj0001426
Score 2.5378542
SecondaryResourceType review_article
Snippet Glioblastoma (GBM) is the most common primary malignant brain tumor in adults, while its frequency in pediatric patients is 10–15%. For this reason, age is...
Glioblastoma (GBM) is the most common primary malignant brain tumor in adults, while its frequency in pediatric patients is 10-15%. For this reason, age is...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 111801
SubjectTerms Age
Brain Neoplasms - epidemiology
Brain Neoplasms - genetics
Brain Neoplasms - therapy
Female
Gender
Glioblastoma
Glioblastoma - genetics
Glioblastoma - therapy
High grade glioma
Humans
Male
Mutation
Prognosis
Risk Factors
Title Impact of age and gender on glioblastoma onset, progression, and management
URI https://dx.doi.org/10.1016/j.mad.2023.111801
https://www.ncbi.nlm.nih.gov/pubmed/36996926
https://www.proquest.com/docview/2793989107
Volume 211
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NS-wwEB905YkX0dWn6xcRHh7EPtt8tNnjIsqq6OkJ8i4hSbOy4rai68GLf7uTNF0Q1IPHhiQNM8lvJpkvgD8IhtKWcpRwU9iE8zJLtOAuEQUzPNU0186_Q15d58MbfnErbufgpI2F8W6VEfsbTA9oHVuOIzWPH8djH-PL8XB4S2Own-EVaIGyfi46sDA4vxxezwA546Hqmu-f-AGtcTO4eU20zxdKmccOGUvDfCKevlI_gxg6W4HlqD-SQbPEVZhzVRfWBhXenSev5IAEj87wVN6FxatoOO_Cr_91aFyDy_MQF0nqEUEoIboqyV0oJ0fqitw9jGuD-jROpon3s54ekeDB1WTvOArdJzOPmXW4OTv9dzJMYkWFxDLBpj5mXEsU2cYJW3CUj6k2ueYCT7LVUjpKC1eyvjVCapvRzDJmjS2YExoZh2jwGzpVXblNIKzMXZmntBQ4oxSpcSPhrMcD1PCc4T1IW0IqG9ON-6oXD6r1K7tXSHvlaa8a2vfgcDbkscm18V1n3nJHfdgwCmXBd8P2W04qPEjeOqIrV788K4pI1ZeoPRU92GhYPFsFy_Fa2Kf51s9-ug1L_qtx-NmBzvTpxe2iLjM1ezD_9y3bizv2HVa572g
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LTwMhEJ4YjY-L0fqqT0yMB-PqdoFdejSNpmrbU02MFwIsbWrsrtF68OJvd2B3a0zUg1cWWDLANwPzDQNwhGAoTCoGAdOJCRhLG4HizAY8oZqFKoqVdfeQ3V7cvmM39_x-BlpVLIyjVZbYX2C6R-uy5LyU5vnzaORifBluDudp9P4zPALNMU4Tx-s7-_jieTSYz7nmageueuXa9CSvsXKvhUbUIYcoE8P8oJx-Mz69ErpageXSeiQXxQBXYcZmNVi7yPDkPH4nx8TzOf1FeQ0WuqXbvAbzD7kvXIPbax8VSfIBQSAhKkvJ0CeTI3lGhk-jXKM1jZ0p4ljWk1Pi-VvF2x2nvvp4ypdZh7ury36rHZT5FAJDOZ24iHElUGFry03CUDuGSseKcdzHRglhoyixKW0azYUyjahhKDXaJNRyhdOGWLABs1me2S0gNI1tGodRyrFHwUNtB9wahwZo31nN6hBWgpSmfGzc5bx4khWr7FGi7KWTvSxkX4eTaZPn4qWNvyqzanbkt-UiURP81eywmkmJ28j5RlRm87dXGSFONQXaTkkdNospno6CxngobEbx9v9-egCL7X63IzvXvdsdWHJfCurPLsxOXt7sHlo1E73vV-0nVhzwMw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Impact+of+age+and+gender+on+glioblastoma+onset%2C+progression%2C+and+management&rft.jtitle=Mechanisms+of+ageing+and+development&rft.au=Colopi%2C+Ambra&rft.au=Fuda%2C+Serena&rft.au=Santi%2C+Samuele&rft.au=Onorato%2C+Angelo&rft.date=2023-04-01&rft.pub=Elsevier+B.V&rft.issn=0047-6374&rft.eissn=1872-6216&rft.volume=211&rft_id=info:doi/10.1016%2Fj.mad.2023.111801&rft.externalDocID=S0047637423000271
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0047-6374&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0047-6374&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0047-6374&client=summon